Skip to main content
Top
Published in: Drugs 2/2005

01-02-2005 | Review Article

Infections Associated with Medical Devices

Pathogenesis, Management and Prophylaxis

Authors: Prof. Dr Christof von Eiff, Bernd Jansen, Wolfgang Kohnen, Karsten Becker

Published in: Drugs | Issue 2/2005

Login to get access

Abstract

The insertion or implantation of foreign bodies has become an indispensable part in almost all fields of medicine. However, medical devices are associated with a definitive risk of bacterial and fungal infections. Foreign body-related infections (FBRIs), particularly catheter-related infections, significantly contribute to the increasing problem of nosocomial infections. While a variety of microorganisms may be involved as pathogens, staphylococci account for the majority of FBRIs. Their ability to adhere to materials and to promote formation of a biofilm is the most important feature of their pathogenicity. This biofilm on the surface of colonised foreign bodies is regarded as the biological correlative for the clinical experience with FBRI, that is, that the host defence mechanisms often seem to be unable to handle the infection and, in particular, to eliminate the microorganisms from the infected device. Since antibacterial chemotherapy is also frequently not able to cure these infections despite the use of antibacterials with proven in vitro activity, removal of implanted devices is often inevitable and has been standard clinical practice. However, in specific circumstances, such as infections of implanted medical devices with coagulase-negative staphylococci, a trial of salvage of the device may be justified. All FBRIs should be treated with antibacterials to which the pathogens have been shown to be susceptible. In addition to systemic antibacterial therapy, an intraluminal application of antibacterial agents, referred to as the ‘antibiotic-lock’ technique, should be considered to circumvent the need for removal, especially in patients with implanted long-term catheters.
To reduce the incidence of intravascular catheter-related bloodstream infections, specific guidelines comprising both technological and nontechnological strategies for prevention have been established. Quality assurance, continuing education, choice of the catheter insertion site, hand hygiene and aseptic techniques are aspects of particular interest. Furthermore, all steps in the pathogenesis of biofilm formation may represent targets against which prevention strategies may be directed. Alteration of the foreign body material surface may lead to a change in specific and nonspecific interactions with micro-organisms and, thus, to a reduced microbial adherence. Medical devices made out of a material that would be antiadhesive or at least colonisation resistant would be the most suitable candidates to avoid colonisation and subsequent infection. Another concept for the prevention of FBRIs involves the impregnation of devices with various substances such as antibacterials, antiseptics and/or metals. Finally, further studies are needed to translate the knowledge on the mechanisms of biofilm formation into applicable therapeutic and preventive strategies.
Footnotes
1
The use of trade names is for product identification purposes only and does not imply endorsement.
 
Literature
1.
go back to reference NNIS System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. Am J Infect Control 2003 Dec; 31(8): 481–98CrossRef NNIS System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. Am J Infect Control 2003 Dec; 31(8): 481–98CrossRef
2.
go back to reference Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000 Mar 7; 132(5): 391–402PubMed Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000 Mar 7; 132(5): 391–402PubMed
3.
go back to reference Mermel LA. Defining intravascular catheter-related infections: a plea for uniformity. Nutrition 1997 Apr; 13 (4 Suppl.): 2S–4SPubMedCrossRef Mermel LA. Defining intravascular catheter-related infections: a plea for uniformity. Nutrition 1997 Apr; 13 (4 Suppl.): 2S–4SPubMedCrossRef
4.
go back to reference Samore MH, Burke JP. Infections of long intravenous lines: new developments and controversies. Curr Clin Top Infect Dis 2000; 20: 256–70PubMed Samore MH, Burke JP. Infections of long intravenous lines: new developments and controversies. Curr Clin Top Infect Dis 2000; 20: 256–70PubMed
5.
go back to reference Sitges-Serra A, Girvent M. Catheter-related bloodstream infections. World J Surg 1999 Jun; 23(6): 589–95PubMedCrossRef Sitges-Serra A, Girvent M. Catheter-related bloodstream infections. World J Surg 1999 Jun; 23(6): 589–95PubMedCrossRef
6.
go back to reference Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988 Jun; 16(3): 128–40PubMedCrossRef Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988 Jun; 16(3): 128–40PubMedCrossRef
7.
go back to reference Eggimann P, Pittet D. Overview of catheter-related infections with special emphasis on prevention based on educational programs. Clin Microbiol Infect 2002 May; 8(5): 295–309PubMedCrossRef Eggimann P, Pittet D. Overview of catheter-related infections with special emphasis on prevention based on educational programs. Clin Microbiol Infect 2002 May; 8(5): 295–309PubMedCrossRef
8.
go back to reference Pearson ML. Guideline for prevention of intravascular device-related infections: the Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1996 Aug; 24(4): 262–93PubMedCrossRef Pearson ML. Guideline for prevention of intravascular device-related infections: the Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1996 Aug; 24(4): 262–93PubMedCrossRef
9.
go back to reference Bouza E, Burillo A, Munoz P. Catheter-related infections: diagnosis and intravascular treatment. Clin Microbiol Infect 2002 May; 8(5): 265–74PubMedCrossRef Bouza E, Burillo A, Munoz P. Catheter-related infections: diagnosis and intravascular treatment. Clin Microbiol Infect 2002 May; 8(5): 265–74PubMedCrossRef
10.
go back to reference Hodge D, Puntis JW. Diagnosis, prevention, and management of catheter related bloodstream infection during long term parenteral nutrition. Arch Dis Child Fetal Neonatal Ed 2002 Jul; 87(1): F21–4PubMedCrossRef Hodge D, Puntis JW. Diagnosis, prevention, and management of catheter related bloodstream infection during long term parenteral nutrition. Arch Dis Child Fetal Neonatal Ed 2002 Jul; 87(1): F21–4PubMedCrossRef
11.
go back to reference Raad II, Hanna HA. Intravascular catheter-related infections: new horizons and recent advances. Arch Intern Med 2002 Apr 22; 162(8): 871–8PubMedCrossRef Raad II, Hanna HA. Intravascular catheter-related infections: new horizons and recent advances. Arch Intern Med 2002 Apr 22; 162(8): 871–8PubMedCrossRef
12.
go back to reference Kristinsson KG. Diagnosis of catheter-related infections. In: Seifert H, Jansen B, Farr BM, editors. Catheter-related infections. New York: Marcel Dekker Inc., 1997: 31–57 Kristinsson KG. Diagnosis of catheter-related infections. In: Seifert H, Jansen B, Farr BM, editors. Catheter-related infections. New York: Marcel Dekker Inc., 1997: 31–57
13.
go back to reference von Eiff C, Peters G. Pathogenesis and detection of biofilm formation on medical implants. In: Jass J, Surman S, Walker J, editors. Medical biofilms: detection, prevention and control. Chichester: Wiley, 2003: 51–72 von Eiff C, Peters G. Pathogenesis and detection of biofilm formation on medical implants. In: Jass J, Surman S, Walker J, editors. Medical biofilms: detection, prevention and control. Chichester: Wiley, 2003: 51–72
14.
go back to reference Sherertz RJ, Raad II, Belani A, et al. Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol 1990 Jan; 28(1): 76–82PubMed Sherertz RJ, Raad II, Belani A, et al. Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol 1990 Jan; 28(1): 76–82PubMed
15.
go back to reference Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 1977 Jun 9; 296(23): 1305–9PubMedCrossRef Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 1977 Jun 9; 296(23): 1305–9PubMedCrossRef
16.
go back to reference Siegman-Igra Y, Anglim AM, Shapiro DE, et al. Diagnosis of vascular catheter-related bloodstream infection: a meta-analysis. J Clin Microbiol 1997 Apr; 35(4): 928–36PubMed Siegman-Igra Y, Anglim AM, Shapiro DE, et al. Diagnosis of vascular catheter-related bloodstream infection: a meta-analysis. J Clin Microbiol 1997 Apr; 35(4): 928–36PubMed
17.
go back to reference Blot F, Nitenberg G, Chachaty E, et al. Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet 1999 Sep 25; 354(9184): 1071–7PubMedCrossRef Blot F, Nitenberg G, Chachaty E, et al. Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet 1999 Sep 25; 354(9184): 1071–7PubMedCrossRef
18.
go back to reference Safdar N, Kluger DM, Maki DG. A review of risk factors for catheter-related bloodstream infection caused by percutaneously inserted, noncuffed central venous catheters: implications for preventive strategies. Medicine (Baltimore) 2002 Nov; 81(6): 466–79CrossRef Safdar N, Kluger DM, Maki DG. A review of risk factors for catheter-related bloodstream infection caused by percutaneously inserted, noncuffed central venous catheters: implications for preventive strategies. Medicine (Baltimore) 2002 Nov; 81(6): 466–79CrossRef
19.
go back to reference Rello J, Ochagavia A, Sabanes E, et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 2000 Sep; 162 (3 Pt 1): 1027–30PubMed Rello J, Ochagavia A, Sabanes E, et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 2000 Sep; 162 (3 Pt 1): 1027–30PubMed
20.
go back to reference Dimick JB, Pelz RK, Consunji R, et al. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg 2001 Feb; 136(2): 229–34PubMedCrossRef Dimick JB, Pelz RK, Consunji R, et al. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg 2001 Feb; 136(2): 229–34PubMedCrossRef
21.
go back to reference Mermel LA. Correction: catheter catheter-related blood stream infections. Ann Intern Med 2000; 133(5): 395 Mermel LA. Correction: catheter catheter-related blood stream infections. Ann Intern Med 2000; 133(5): 395
22.
go back to reference O’Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections: Centers for Disease Control and Prevention. MMWR Recomm Rep 2002 Aug 9; 51(RR-10): 1–29PubMed O’Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections: Centers for Disease Control and Prevention. MMWR Recomm Rep 2002 Aug 9; 51(RR-10): 1–29PubMed
23.
24.
go back to reference Hugonnet S, Sax H, Eggimann P, et al. Nosocomial bloodstream infection and clinical sepsis. Emerg Infect Dis 2004; 10(1): 76–81PubMedCrossRef Hugonnet S, Sax H, Eggimann P, et al. Nosocomial bloodstream infection and clinical sepsis. Emerg Infect Dis 2004; 10(1): 76–81PubMedCrossRef
25.
go back to reference von Eiff C, Peters G, Heilmann C. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis 2002 Nov; 2(11): 677–85CrossRef von Eiff C, Peters G, Heilmann C. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis 2002 Nov; 2(11): 677–85CrossRef
26.
go back to reference Peters G, Locci R, Pulverer G. Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J Infect Dis 1982 Oct; 146(4): 479–82PubMedCrossRef Peters G, Locci R, Pulverer G. Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J Infect Dis 1982 Oct; 146(4): 479–82PubMedCrossRef
27.
go back to reference Dickinson GM, Bisno AL. Infections associated with indwelling devices: infections related to extravascular devices. Antimicrob Agents Chemother 1989 May; 33(5): 602–7PubMedCrossRef Dickinson GM, Bisno AL. Infections associated with indwelling devices: infections related to extravascular devices. Antimicrob Agents Chemother 1989 May; 33(5): 602–7PubMedCrossRef
28.
go back to reference Veenstra GJ, Cremers FF, van Dijk H, et al. Ultrastructural organization and regulation of a biomaterial adhesin of Staphylococcus epidermidis. J Bacteriol 1996 Jan; 178(2): 537–41PubMed Veenstra GJ, Cremers FF, van Dijk H, et al. Ultrastructural organization and regulation of a biomaterial adhesin of Staphylococcus epidermidis. J Bacteriol 1996 Jan; 178(2): 537–41PubMed
29.
go back to reference Heilmann C, Hussain M, Peters G, et al. Evidence for autolysin-mediated primary attachment of Staphylococcus epidermidis to a polystyrene surface. Mol Microbiol 1997 Jun; 24(5): 1013–24PubMedCrossRef Heilmann C, Hussain M, Peters G, et al. Evidence for autolysin-mediated primary attachment of Staphylococcus epidermidis to a polystyrene surface. Mol Microbiol 1997 Jun; 24(5): 1013–24PubMedCrossRef
30.
go back to reference Cucarella C, Solano C, Valle J, et al. Bap, a Staphylococcus aureus surface protein involved in biofilm formation. J Bacteriol 2001 May; 183(9): 2888–96PubMedCrossRef Cucarella C, Solano C, Valle J, et al. Bap, a Staphylococcus aureus surface protein involved in biofilm formation. J Bacteriol 2001 May; 183(9): 2888–96PubMedCrossRef
32.
go back to reference Muller E, Hübner J, Gutierrez N, et al. Isolation and characterization of transposon mutants of Staphylococcus epidermidis deficient in capsular polysaccharide/adhesin and slime. Infect Immun 1993 Feb; 61(2): 551–8PubMed Muller E, Hübner J, Gutierrez N, et al. Isolation and characterization of transposon mutants of Staphylococcus epidermidis deficient in capsular polysaccharide/adhesin and slime. Infect Immun 1993 Feb; 61(2): 551–8PubMed
33.
go back to reference Shiro H, Muller E, Gutierrez N, et al. Transposon mutants of Staphylococcus epidermidis deficient in elaboration of capsular polysaccharide/adhesin and slime are avirulent in a rabbit model of endocarditis. J Infect Dis 1994 May; 169(5): 1042–9PubMedCrossRef Shiro H, Muller E, Gutierrez N, et al. Transposon mutants of Staphylococcus epidermidis deficient in elaboration of capsular polysaccharide/adhesin and slime are avirulent in a rabbit model of endocarditis. J Infect Dis 1994 May; 169(5): 1042–9PubMedCrossRef
34.
go back to reference Herrmann M, Vaudaux PE, Pittet D, et al. Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J Infect Dis 1988 Oct; 158(4): 693–701PubMedCrossRef Herrmann M, Vaudaux PE, Pittet D, et al. Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J Infect Dis 1988 Oct; 158(4): 693–701PubMedCrossRef
35.
go back to reference Herrmann M, Hartleib J, Kehrel B, et al. Interaction of von Willebrand factor with Staphylococcus aureus. J Infect Dis1997 Oct; 176(4): 984–91PubMedCrossRef Herrmann M, Hartleib J, Kehrel B, et al. Interaction of von Willebrand factor with Staphylococcus aureus. J Infect Dis1997 Oct; 176(4): 984–91PubMedCrossRef
36.
go back to reference Dickinson GM, Bisno AL. Infections associated with indwelling devices: concepts of pathogenesis; infections associated with intravascular devices. Antimicrob Agents Chemother 1989 May; 33(5): 597–601PubMedCrossRef Dickinson GM, Bisno AL. Infections associated with indwelling devices: concepts of pathogenesis; infections associated with intravascular devices. Antimicrob Agents Chemother 1989 May; 33(5): 597–601PubMedCrossRef
37.
go back to reference Hussain M, Heilmann C, Peters G, et al. Teichoic acid enhances adhesion of Staphylococcus epidermidis to immobilized fibronectin. Microb Pathog 2001 Dec; 31(6): 261–70PubMedCrossRef Hussain M, Heilmann C, Peters G, et al. Teichoic acid enhances adhesion of Staphylococcus epidermidis to immobilized fibronectin. Microb Pathog 2001 Dec; 31(6): 261–70PubMedCrossRef
38.
go back to reference Mack D, Fischer W, Krokotsch A, et al. The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis. J Bacteriol 1996 Jan; 178(1): 175–83PubMed Mack D, Fischer W, Krokotsch A, et al. The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis. J Bacteriol 1996 Jan; 178(1): 175–83PubMed
39.
go back to reference Heilmann C, Schweitzer O, Gerke C, et al. Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis. Mol Microbiol 1996 Jun; 20(5): 1083–91PubMedCrossRef Heilmann C, Schweitzer O, Gerke C, et al. Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis. Mol Microbiol 1996 Jun; 20(5): 1083–91PubMedCrossRef
40.
go back to reference Gerke C, Kraft A, Süβmuth R, et al. Characterization of the N-acetylglucosaminyltransferase activity involved in the biosynthesis of the Staphylococcus epidermidis polysaccharide intercellular adhesin. J Biol Chem 1998 Jul 17; 273(29): 18586–93PubMedCrossRef Gerke C, Kraft A, Süβmuth R, et al. Characterization of the N-acetylglucosaminyltransferase activity involved in the biosynthesis of the Staphylococcus epidermidis polysaccharide intercellular adhesin. J Biol Chem 1998 Jul 17; 273(29): 18586–93PubMedCrossRef
41.
go back to reference Mack D, Rohde H, Dobinsky S, et al. Identification of three essential regulatory gene loci governing expression of Staphylococcus epidermidis polysaccharide intercellular adhesin and biofilm formation. Infect Immun 2000 Jul; 68(7): 3799–807PubMedCrossRef Mack D, Rohde H, Dobinsky S, et al. Identification of three essential regulatory gene loci governing expression of Staphylococcus epidermidis polysaccharide intercellular adhesin and biofilm formation. Infect Immun 2000 Jul; 68(7): 3799–807PubMedCrossRef
42.
go back to reference Rupp ME, Ulphani JS, Fey PD, et al. Characterization of Staphylococcus epidermidis polysaccharide intercellular adhesin/hemagglutinin in the pathogenesis of intravascular catheter-associated infection in a rat model. Infect Immun 1999 May; 67(5): 2656–9PubMed Rupp ME, Ulphani JS, Fey PD, et al. Characterization of Staphylococcus epidermidis polysaccharide intercellular adhesin/hemagglutinin in the pathogenesis of intravascular catheter-associated infection in a rat model. Infect Immun 1999 May; 67(5): 2656–9PubMed
43.
go back to reference Rupp ME, Ulphani JS, Fey PD, et al. Characterization of the importance of polysaccharide intercellular adhesin/hemagglutinin of Staphylococcus epidermidis in the pathogenesis of biomaterial-based infection in a mouse foreign body infection model. Infect Immun 1999 May; 67(5): 2627–32PubMed Rupp ME, Ulphani JS, Fey PD, et al. Characterization of the importance of polysaccharide intercellular adhesin/hemagglutinin of Staphylococcus epidermidis in the pathogenesis of biomaterial-based infection in a mouse foreign body infection model. Infect Immun 1999 May; 67(5): 2627–32PubMed
44.
go back to reference Ziebuhr W, Heilmann C, Götz F, et al. Detection of the intercellular adhesion gene cluster (ica) and phase variation in Staphylococcus epidermidis blood culture strains and mucosal isolates. Infect Immun 1997 Mar; 65(3): 890–6PubMed Ziebuhr W, Heilmann C, Götz F, et al. Detection of the intercellular adhesion gene cluster (ica) and phase variation in Staphylococcus epidermidis blood culture strains and mucosal isolates. Infect Immun 1997 Mar; 65(3): 890–6PubMed
45.
go back to reference Dobinsky S, Kiel K, Rohde H, et al. Glucose-related dissociation between icaADBC transcription and biofilm expression by Staphylococcus epidermidis: evidence for an additional factor required for polysaccharide intercellular adhesin synthesis. J Bacteriol 2003 May; 185(9): 2879–86PubMedCrossRef Dobinsky S, Kiel K, Rohde H, et al. Glucose-related dissociation between icaADBC transcription and biofilm expression by Staphylococcus epidermidis: evidence for an additional factor required for polysaccharide intercellular adhesin synthesis. J Bacteriol 2003 May; 185(9): 2879–86PubMedCrossRef
46.
go back to reference Hussain M, Herrmann M, von Eiff C, et al. A 140-kilodalton extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on surfaces. Infect Immun 1997 Feb; 65(2): 519–24PubMed Hussain M, Herrmann M, von Eiff C, et al. A 140-kilodalton extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on surfaces. Infect Immun 1997 Feb; 65(2): 519–24PubMed
47.
go back to reference Peters G, Locci R, Pulverer G. Microbial colonization of prosthetic devices. II: scanning electron microscopy of naturally infected intravenous catheters. Zentralbl Bakteriol Mikrobiol Hyg [B] 1981; 173(5): 293–9 Peters G, Locci R, Pulverer G. Microbial colonization of prosthetic devices. II: scanning electron microscopy of naturally infected intravenous catheters. Zentralbl Bakteriol Mikrobiol Hyg [B] 1981; 173(5): 293–9
48.
go back to reference Davies DG, Parsek MR, Pearson JP, et al. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 1998 Apr 10; 280(5361): 295–8PubMedCrossRef Davies DG, Parsek MR, Pearson JP, et al. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 1998 Apr 10; 280(5361): 295–8PubMedCrossRef
49.
go back to reference Yarwood JM, Bartels DJ, Volper EM, et al. Quorum sensing in Staphylococcus aureus biofilms. J Bacteriol 2004 Mar; 186(6): 1838–50PubMedCrossRef Yarwood JM, Bartels DJ, Volper EM, et al. Quorum sensing in Staphylococcus aureus biofilms. J Bacteriol 2004 Mar; 186(6): 1838–50PubMedCrossRef
50.
go back to reference Herrmann M, Weyand M, Greshake B, et al. Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation. Circulation 1997 Feb 18; 95(4): 814–7PubMedCrossRef Herrmann M, Weyand M, Greshake B, et al. Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation. Circulation 1997 Feb 18; 95(4): 814–7PubMedCrossRef
51.
go back to reference von Eiff C, Heilmann C, Peters G. New aspects in the molecular basis of polymer-associated infections due to staphylococci. Eur J Clin Microbiol Infect Dis 1999 Dec; 18(12): 843–6CrossRef von Eiff C, Heilmann C, Peters G. New aspects in the molecular basis of polymer-associated infections due to staphylococci. Eur J Clin Microbiol Infect Dis 1999 Dec; 18(12): 843–6CrossRef
52.
go back to reference Berns JS. Infection with antimicrobial-resistant microorganisms in dialysis patients. Semin Dial 2003 Jan; 16(1): 30–7PubMedCrossRef Berns JS. Infection with antimicrobial-resistant microorganisms in dialysis patients. Semin Dial 2003 Jan; 16(1): 30–7PubMedCrossRef
53.
go back to reference Carratalà J. Role of antibiotic prophylaxis for the prevention of intravascular catheter-related infection. Clin Microbiol Infect 2001; 7 Suppl. 4: 83–90PubMedCrossRef Carratalà J. Role of antibiotic prophylaxis for the prevention of intravascular catheter-related infection. Clin Microbiol Infect 2001; 7 Suppl. 4: 83–90PubMedCrossRef
54.
go back to reference Fätkenheuer G, Cornely O, Seifert H. Clinical management of catheter-related infections. Clin Microbiol Infect 2002 Sep; 8(9): 545–50PubMedCrossRef Fätkenheuer G, Cornely O, Seifert H. Clinical management of catheter-related infections. Clin Microbiol Infect 2002 Sep; 8(9): 545–50PubMedCrossRef
55.
go back to reference Graninger W, Assadian O, Lagler H, et al. The role of glycopeptides in the treatment of intravascular catheter-related infections. Clin Microbiol Infect 2002 May; 8(5): 310–5PubMedCrossRef Graninger W, Assadian O, Lagler H, et al. The role of glycopeptides in the treatment of intravascular catheter-related infections. Clin Microbiol Infect 2002 May; 8(5): 310–5PubMedCrossRef
56.
go back to reference Karchmer AW, Longworth DL. Infections of intracardiac devices. Infect Dis Clin North Am 2002 Jun; 16(2): 477–505, xiiPubMedCrossRef Karchmer AW, Longworth DL. Infections of intracardiac devices. Infect Dis Clin North Am 2002 Jun; 16(2): 477–505, xiiPubMedCrossRef
57.
go back to reference Kovalik EC, Schwab SJ. Treatment approaches for infected hemodialysis vascular catheters. Curr Opin Nephrol Hypertens 2002 Nov; 11(6): 593–6PubMedCrossRef Kovalik EC, Schwab SJ. Treatment approaches for infected hemodialysis vascular catheters. Curr Opin Nephrol Hypertens 2002 Nov; 11(6): 593–6PubMedCrossRef
58.
go back to reference Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001 May 1; 32(9): 1249–72PubMedCrossRef Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001 May 1; 32(9): 1249–72PubMedCrossRef
59.
go back to reference Nichols RL, Raad II. Management of bacterial complications in critically ill patients: surgical wound and catheter-related infections. Diagn Microbiol Infect Dis 1999 Feb; 33(2): 121–30PubMedCrossRef Nichols RL, Raad II. Management of bacterial complications in critically ill patients: surgical wound and catheter-related infections. Diagn Microbiol Infect Dis 1999 Feb; 33(2): 121–30PubMedCrossRef
60.
go back to reference Oppenheim BA. Optimal management of central venous catheter-related infections: what is the evidence? J Infect 2000 Jan; 40(1): 26–30PubMedCrossRef Oppenheim BA. Optimal management of central venous catheter-related infections: what is the evidence? J Infect 2000 Jan; 40(1): 26–30PubMedCrossRef
61.
go back to reference Paiva JA, Pereira JM. Treatment of the afebrile patient after catheter withdrawal: drugs and duration. Clin Microbiol Infect 2002 May; 8(5): 290–4PubMedCrossRef Paiva JA, Pereira JM. Treatment of the afebrile patient after catheter withdrawal: drugs and duration. Clin Microbiol Infect 2002 May; 8(5): 290–4PubMedCrossRef
62.
63.
go back to reference Rodríguez-Bano J. Selection of empiric therapy in patients with catheter-related infections. Clin Microbiol Infect 2002 May; 8(5): 275–81PubMedCrossRef Rodríguez-Bano J. Selection of empiric therapy in patients with catheter-related infections. Clin Microbiol Infect 2002 May; 8(5): 275–81PubMedCrossRef
64.
go back to reference Seifert H, Strate A, Pulverer G. Nosocomial bacteremia due to Acinetobacter baumannii: clinical features, epidemiology, and predictors of mortality. Medicine (Baltimore) 1995 Nov; 74(6): 340–9CrossRef Seifert H, Strate A, Pulverer G. Nosocomial bacteremia due to Acinetobacter baumannii: clinical features, epidemiology, and predictors of mortality. Medicine (Baltimore) 1995 Nov; 74(6): 340–9CrossRef
65.
go back to reference Elting LS, Bodey GP. Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: increasing incidence of catheter-related infections. Medicine (Baltimore) 1990 Sep; 69(5): 296–306 Elting LS, Bodey GP. Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: increasing incidence of catheter-related infections. Medicine (Baltimore) 1990 Sep; 69(5): 296–306
66.
go back to reference Seifert H, Strate A, Schulze A, et al. Vascular catheter-related bloodstream infection due to Acinetobacter johnsonii (formerly Acinetobacter calcoaceticus var. Iwoffi): report of 13 cases. Clin Infect Dis 1993 Oct; 17(4): 632–6PubMedCrossRef Seifert H, Strate A, Schulze A, et al. Vascular catheter-related bloodstream infection due to Acinetobacter johnsonii (formerly Acinetobacter calcoaceticus var. Iwoffi): report of 13 cases. Clin Infect Dis 1993 Oct; 17(4): 632–6PubMedCrossRef
67.
go back to reference Benoit JL, Carandang G, Sitrin M, et al. Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home. Clin Infect Dis 1995 Nov; 21(5): 1286–8PubMedCrossRef Benoit JL, Carandang G, Sitrin M, et al. Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home. Clin Infect Dis 1995 Nov; 21(5): 1286–8PubMedCrossRef
68.
go back to reference Robinson D, Suhocki P, Schwab SJ. Treatment of infected tunneled venous access hemodialysis catheters with guidewire exchange. Kidney Int 1998 Jun; 53(6): 1792–4PubMedCrossRef Robinson D, Suhocki P, Schwab SJ. Treatment of infected tunneled venous access hemodialysis catheters with guidewire exchange. Kidney Int 1998 Jun; 53(6): 1792–4PubMedCrossRef
69.
go back to reference Beathard GA. Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol 1999 May; 10(5): 1045–9PubMed Beathard GA. Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol 1999 May; 10(5): 1045–9PubMed
70.
go back to reference Martinez E, Mensa J, Rovira M, et al. Central venous catheter exchange by guidewire for treatment of catheter-related bacteraemia in patients undergoing BMT or intensive chemotherapy. Bone Marrow Transplant 1999 Jan; 23(1): 41–4PubMedCrossRef Martinez E, Mensa J, Rovira M, et al. Central venous catheter exchange by guidewire for treatment of catheter-related bacteraemia in patients undergoing BMT or intensive chemotherapy. Bone Marrow Transplant 1999 Jan; 23(1): 41–4PubMedCrossRef
71.
go back to reference Shaffer D. Catheter-related sepsis complicating long-term, tunnelled central venous dialysis catheters: management by guidewire exchange. Am J Kidney Dis 1995 Apr; 25(4): 593–6PubMedCrossRef Shaffer D. Catheter-related sepsis complicating long-term, tunnelled central venous dialysis catheters: management by guidewire exchange. Am J Kidney Dis 1995 Apr; 25(4): 593–6PubMedCrossRef
72.
go back to reference Schuman ES, Winters V, Gross GF, et al. Management of Hickman catheter sepsis. Am J Surg 1985 May; 149(5): 627–8PubMedCrossRef Schuman ES, Winters V, Gross GF, et al. Management of Hickman catheter sepsis. Am J Surg 1985 May; 149(5): 627–8PubMedCrossRef
73.
go back to reference Press OW, Ramsey PG, Larson EB, et al. Hickman catheter infections in patients with malignancies. Medicine (Baltimore) 1984 Jul; 63(4): 189–200 Press OW, Ramsey PG, Larson EB, et al. Hickman catheter infections in patients with malignancies. Medicine (Baltimore) 1984 Jul; 63(4): 189–200
74.
go back to reference Allison DG, McBain AJ, Gilbert P. Microbial biofilms: problems of control. In: Allison DG, Gilbert P, Lappin-Scott H, et al., editors. Community structure and cooperation in biofilms. Reading: Society for General Microbiology Press, 2000: 309–27CrossRef Allison DG, McBain AJ, Gilbert P. Microbial biofilms: problems of control. In: Allison DG, Gilbert P, Lappin-Scott H, et al., editors. Community structure and cooperation in biofilms. Reading: Society for General Microbiology Press, 2000: 309–27CrossRef
75.
go back to reference Ceri H, Olson ME, Stremick C, et al. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999 Jun; 37(6): 1771–6PubMed Ceri H, Olson ME, Stremick C, et al. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999 Jun; 37(6): 1771–6PubMed
76.
go back to reference Espersen F, Frimodt-Moller N, Corneliussen L, et al. Effect of treatment with methicillin and gentamicin in a new experimental mouse model of foreign body infection. Antimicrob Agents Chemother 1994 Sep; 38(9): 2047–53PubMedCrossRef Espersen F, Frimodt-Moller N, Corneliussen L, et al. Effect of treatment with methicillin and gentamicin in a new experimental mouse model of foreign body infection. Antimicrob Agents Chemother 1994 Sep; 38(9): 2047–53PubMedCrossRef
77.
go back to reference Rachid S, Ohlsen K, Witte W, et al. Effect of subinhibitory antibiotic concentrations on polysaccharide intercellular adhesin expression in biofilm-forming Staphylococcus epidermidis. Antimicrob Agents Chemother 2000 Dec; 44(12): 3357–63PubMedCrossRef Rachid S, Ohlsen K, Witte W, et al. Effect of subinhibitory antibiotic concentrations on polysaccharide intercellular adhesin expression in biofilm-forming Staphylococcus epidermidis. Antimicrob Agents Chemother 2000 Dec; 44(12): 3357–63PubMedCrossRef
78.
go back to reference Wilcox MH, Finch RG, Smith DG, et al. Effects of carbon dioxide and sub-lethal levels of antibiotics on adherence of coagulase-negative staphylococci to polystyrene and silicone rubber. J Antimicrob Chemother 1991 May; 27(5): 577–87PubMedCrossRef Wilcox MH, Finch RG, Smith DG, et al. Effects of carbon dioxide and sub-lethal levels of antibiotics on adherence of coagulase-negative staphylococci to polystyrene and silicone rubber. J Antimicrob Chemother 1991 May; 27(5): 577–87PubMedCrossRef
79.
go back to reference Bisognano C, Vaudaux PE, Lew DP, et al. Increased expression of fibronectin-binding proteins by fluoroquinolone-resistant Staphylococcus aureus exposed to subinhibitory levels of ciprofloxacin. Antimicrob Agents Chemother 1997 May; 41(5): 906–13PubMed Bisognano C, Vaudaux PE, Lew DP, et al. Increased expression of fibronectin-binding proteins by fluoroquinolone-resistant Staphylococcus aureus exposed to subinhibitory levels of ciprofloxacin. Antimicrob Agents Chemother 1997 May; 41(5): 906–13PubMed
80.
go back to reference Roehrborn AA, Hansbrough JF, Gualdoni B, et al. Lipid-based slow-release formulation of amikacin sulfate reduces foreign body-associated infections in mice. Antimicrob Agents Chemother 1995 Aug; 39(8): 1752–5PubMedCrossRef Roehrborn AA, Hansbrough JF, Gualdoni B, et al. Lipid-based slow-release formulation of amikacin sulfate reduces foreign body-associated infections in mice. Antimicrob Agents Chemother 1995 Aug; 39(8): 1752–5PubMedCrossRef
81.
go back to reference Messing B, Peitra-Cohen S, Debure A, et al. Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. JPEN J Parenter Enteral Nutr 1988 Mar; 12(2): 185–9PubMedCrossRef Messing B, Peitra-Cohen S, Debure A, et al. Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. JPEN J Parenter Enteral Nutr 1988 Mar; 12(2): 185–9PubMedCrossRef
82.
go back to reference Kentos A, Struelens MJ, Thys JP. Antibiotic-lock technique for the treatment of central venous catheter infections. Clin Infect Dis 1996 Aug; 23(2): 418–9PubMedCrossRef Kentos A, Struelens MJ, Thys JP. Antibiotic-lock technique for the treatment of central venous catheter infections. Clin Infect Dis 1996 Aug; 23(2): 418–9PubMedCrossRef
83.
go back to reference Ruiz-Valverde MP, Barbera JR, Segarra A, et al. Successful treatment of catheter-related sepsis and extraluminal catheter thrombosis with vancomycin and fraxiparin without catheter removal. Nephron 1997; 75(3): 354–5PubMedCrossRef Ruiz-Valverde MP, Barbera JR, Segarra A, et al. Successful treatment of catheter-related sepsis and extraluminal catheter thrombosis with vancomycin and fraxiparin without catheter removal. Nephron 1997; 75(3): 354–5PubMedCrossRef
84.
go back to reference Capdevila JA, Segarra A, Planes AM, et al. Successful treatment of haemodialysis catheter-related sepsis without catheter removal. Nephrol Dial Transplant 1993; 8(3): 231–4PubMed Capdevila JA, Segarra A, Planes AM, et al. Successful treatment of haemodialysis catheter-related sepsis without catheter removal. Nephrol Dial Transplant 1993; 8(3): 231–4PubMed
85.
go back to reference Krishnasami Z, Carlton D, Bimbo L, et al. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int 2002 Mar; 61(3): 1136–42PubMedCrossRef Krishnasami Z, Carlton D, Bimbo L, et al. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int 2002 Mar; 61(3): 1136–42PubMedCrossRef
86.
go back to reference La Quaglia MP, Caldwell C, Lucas A, et al. A prospective randomized double-blind trial of bolus urokinase in the treatment of established Hickman catheter sepsis in children. J Pediatr Surg 1994 Jun; 29(6): 742–5PubMedCrossRef La Quaglia MP, Caldwell C, Lucas A, et al. A prospective randomized double-blind trial of bolus urokinase in the treatment of established Hickman catheter sepsis in children. J Pediatr Surg 1994 Jun; 29(6): 742–5PubMedCrossRef
87.
go back to reference Jones GR, Konsler GK, Dunaway RP. Urokinase in the treatment of bacteremia and candidemia in patients with right atrial catheters. Am J Infect Control 1996 Jun; 24(3): 160–6PubMedCrossRef Jones GR, Konsler GK, Dunaway RP. Urokinase in the treatment of bacteremia and candidemia in patients with right atrial catheters. Am J Infect Control 1996 Jun; 24(3): 160–6PubMedCrossRef
88.
go back to reference Capdevila JA, Gavalda J, Fortea J, et al. Lack of antimicrobial activity of sodium heparin for treating experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique. Clin Microbiol Infect 2001 Apr; 7(4): 206–12PubMedCrossRef Capdevila JA, Gavalda J, Fortea J, et al. Lack of antimicrobial activity of sodium heparin for treating experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique. Clin Microbiol Infect 2001 Apr; 7(4): 206–12PubMedCrossRef
89.
go back to reference Sieradzki K, Roberts RB, Serur D, et al. Heterogeneously vancomycin-resistant Staphylococcus epidermidis strain causing recurrent peritonitis in a dialysis patient during vancomycin therapy. J Clin Microbiol 1999 Jan; 37(1): 39–44PubMed Sieradzki K, Roberts RB, Serur D, et al. Heterogeneously vancomycin-resistant Staphylococcus epidermidis strain causing recurrent peritonitis in a dialysis patient during vancomycin therapy. J Clin Microbiol 1999 Jan; 37(1): 39–44PubMed
90.
go back to reference Traub WH, Leonhard B, Bauer D. Taurolidine: in vitro activity against multiple-antibiotic-resistant, nosocomially significant clinical isolates of Staphylococcus aureus, Enterococcus faecium, and diverse Enterobacteriaceae. Chemotherapy 1993 Sep; 39(5): 322–30PubMedCrossRef Traub WH, Leonhard B, Bauer D. Taurolidine: in vitro activity against multiple-antibiotic-resistant, nosocomially significant clinical isolates of Staphylococcus aureus, Enterococcus faecium, and diverse Enterobacteriaceae. Chemotherapy 1993 Sep; 39(5): 322–30PubMedCrossRef
91.
go back to reference Jones DS, Gorman SP, McCafferty DF, et al. The effects of three non-antibiotic, antimicrobial agents on the surface hydrophobicity of certain micro-organisms evaluated by different methods. J Appl Bacteriol 1991 Sep; 71(3): 218–27PubMedCrossRef Jones DS, Gorman SP, McCafferty DF, et al. The effects of three non-antibiotic, antimicrobial agents on the surface hydrophobicity of certain micro-organisms evaluated by different methods. J Appl Bacteriol 1991 Sep; 71(3): 218–27PubMedCrossRef
92.
go back to reference Shah CB, Mittelman MW, Costerton JW, et al. Antimicrobial activity of a novel catheter lock solution. Antimicrob Agents Chemother 2002 Jun; 46(6): 1674–9PubMedCrossRef Shah CB, Mittelman MW, Costerton JW, et al. Antimicrobial activity of a novel catheter lock solution. Antimicrob Agents Chemother 2002 Jun; 46(6): 1674–9PubMedCrossRef
93.
go back to reference Dannenberg C, Bierbach U, Rothe A, et al. Ethanol-lock technique in the treatment of bloodstream infections in pediatric oncology patients with broviac catheter. J Pediatr Hematol Oncol 2003 Aug; 25(8): 616–21PubMedCrossRef Dannenberg C, Bierbach U, Rothe A, et al. Ethanol-lock technique in the treatment of bloodstream infections in pediatric oncology patients with broviac catheter. J Pediatr Hematol Oncol 2003 Aug; 25(8): 616–21PubMedCrossRef
94.
go back to reference Arnow PM, Quimosing EM, Beach M. Consequences of intravascular catheter sepsis. Clin Infect Dis 1993 Jun; 16(6): 778–84PubMedCrossRef Arnow PM, Quimosing EM, Beach M. Consequences of intravascular catheter sepsis. Clin Infect Dis 1993 Jun; 16(6): 778–84PubMedCrossRef
95.
go back to reference Rotstein C, Brock L, Roberts RS. The incidence of first Hickman catheter-related infection and predictors of catheter removal in cancer patients. Infect Control Hosp Epidemiol 1995 Aug; 16(8): 451–8PubMedCrossRef Rotstein C, Brock L, Roberts RS. The incidence of first Hickman catheter-related infection and predictors of catheter removal in cancer patients. Infect Control Hosp Epidemiol 1995 Aug; 16(8): 451–8PubMedCrossRef
96.
go back to reference Perdreau-Remington F, Stefanik D, Peters G, et al. A four-year prospective study on microbial ecology of explanted prosthetic hips in 52 patients with ‘aseptic’ prosthetic joint loosening. Eur J Clin Microbiol Infect Dis 1996 Feb; 15(2): 160–5PubMedCrossRef Perdreau-Remington F, Stefanik D, Peters G, et al. A four-year prospective study on microbial ecology of explanted prosthetic hips in 52 patients with ‘aseptic’ prosthetic joint loosening. Eur J Clin Microbiol Infect Dis 1996 Feb; 15(2): 160–5PubMedCrossRef
97.
go back to reference Raad I, Davis S, Khan A, et al. Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococcal bacteremia. Infect Control Hosp Epidemiol 1992 Apr; 13(4): 215–21PubMedCrossRef Raad I, Davis S, Khan A, et al. Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococcal bacteremia. Infect Control Hosp Epidemiol 1992 Apr; 13(4): 215–21PubMedCrossRef
98.
go back to reference Flynn PM, Shenep JL, Stokes DC, et al. In situ management of confirmed central venous catheter-related bacteremia. Pediatr Infect Dis J 1987 Aug; 6(8): 729–34PubMedCrossRef Flynn PM, Shenep JL, Stokes DC, et al. In situ management of confirmed central venous catheter-related bacteremia. Pediatr Infect Dis J 1987 Aug; 6(8): 729–34PubMedCrossRef
99.
go back to reference Gagnon RF, Richards GK, Subang R. Experimental Staphylococcus epidermidis implant infection in the mouse: kinetics of rifampin and vancomycin action. ASAIO J 1992 Jul; 38(3): M596–9PubMedCrossRef Gagnon RF, Richards GK, Subang R. Experimental Staphylococcus epidermidis implant infection in the mouse: kinetics of rifampin and vancomycin action. ASAIO J 1992 Jul; 38(3): M596–9PubMedCrossRef
100.
go back to reference Gagnon RF, Richards GK, Wiesenfeld L. Staphylococcus epidermidis biofilms: unexpected outcome of double and triple antibiotic combinations with rifampin. ASAIO Trans 1991 Jul; 37(3): M158–60PubMed Gagnon RF, Richards GK, Wiesenfeld L. Staphylococcus epidermidis biofilms: unexpected outcome of double and triple antibiotic combinations with rifampin. ASAIO Trans 1991 Jul; 37(3): M158–60PubMed
101.
go back to reference Curtin J, Cormican M, Fleming G, et al. Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob Agents Chemother 2003 Oct; 47(10): 3145–8PubMedCrossRef Curtin J, Cormican M, Fleming G, et al. Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob Agents Chemother 2003 Oct; 47(10): 3145–8PubMedCrossRef
102.
go back to reference Boyce JM, Mermel LA, Zervos MJ, et al. Controlling vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 1995 Nov; 16(11): 634–7PubMedCrossRef Boyce JM, Mermel LA, Zervos MJ, et al. Controlling vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 1995 Nov; 16(11): 634–7PubMedCrossRef
103.
go back to reference Gaillard JL, Merlino R, Pajot N, et al. Conventional and nonconventional modes of vancomycin administration to decontaminate the internal surface of catheters colonized with coagulase-negative staphylococci. JPEN J Parenter Enteral Nutr 1990 Nov; 14(6): 593–7PubMedCrossRef Gaillard JL, Merlino R, Pajot N, et al. Conventional and nonconventional modes of vancomycin administration to decontaminate the internal surface of catheters colonized with coagulase-negative staphylococci. JPEN J Parenter Enteral Nutr 1990 Nov; 14(6): 593–7PubMedCrossRef
104.
go back to reference Staphylococcus aureus resistant to vancomycin: United States, 2002. MMWR Morb Mortal Wkly Rep 2002 Jul 5; 51 (26): 565–7 Staphylococcus aureus resistant to vancomycin: United States, 2002. MMWR Morb Mortal Wkly Rep 2002 Jul 5; 51 (26): 565–7
105.
go back to reference Vancomycin-resistant Staphylococcus aureus: Pennsylvania, 2002 [published erratum appears in MMWR Morb Mortal Wkly Rep 2002 Oct 18; 51 (41): 931]. MMWR Morb Mortal Wkly Rep 2002 Oct 11; 51 (40): 902 Vancomycin-resistant Staphylococcus aureus: Pennsylvania, 2002 [published erratum appears in MMWR Morb Mortal Wkly Rep 2002 Oct 18; 51 (41): 931]. MMWR Morb Mortal Wkly Rep 2002 Oct 11; 51 (40): 902
106.
go back to reference Fowler Jr VG, Sanders LL, Sexton DJ, et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 1998 Sep; 27(3): 478–86PubMedCrossRef Fowler Jr VG, Sanders LL, Sexton DJ, et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 1998 Sep; 27(3): 478–86PubMedCrossRef
107.
go back to reference Libman H, Arbeit RD. Complications associated with Staphylococcus aureus bacteremia. Arch Intern Med 1984 Mar; 144(3): 541–5PubMedCrossRef Libman H, Arbeit RD. Complications associated with Staphylococcus aureus bacteremia. Arch Intern Med 1984 Mar; 144(3): 541–5PubMedCrossRef
108.
go back to reference Benezra D, Kiehn TE, Gold JW, et al. Prospective study of infections in indwelling central venous catheters using quantitative blood cultures. Am J Med 1988 Oct; 85(4): 495–8PubMedCrossRef Benezra D, Kiehn TE, Gold JW, et al. Prospective study of infections in indwelling central venous catheters using quantitative blood cultures. Am J Med 1988 Oct; 85(4): 495–8PubMedCrossRef
109.
go back to reference Dugdale DC, Ramsey PG. Staphylococcus aureus bacteremia in patients with Hickman catheters. Am J Med 1990 Aug; 89(2): 137–41PubMedCrossRef Dugdale DC, Ramsey PG. Staphylococcus aureus bacteremia in patients with Hickman catheters. Am J Med 1990 Aug; 89(2): 137–41PubMedCrossRef
110.
go back to reference Williams N, Carlson GL, Scott NA, et al. Incidence and management of catheter-related sepsis in patients receiving home parenteral nutrition. Br J Surg 1994 Mar; 81(3): 392–4PubMedCrossRef Williams N, Carlson GL, Scott NA, et al. Incidence and management of catheter-related sepsis in patients receiving home parenteral nutrition. Br J Surg 1994 Mar; 81(3): 392–4PubMedCrossRef
111.
go back to reference Rubin LG, Shih S, Shende A, et al. Cure of implantable venous port-associated bloodstream infections in pediatric hematology-oncology patients without catheter removal. Clin Infect Dis 1999 Jul; 29(1): 102–5PubMedCrossRef Rubin LG, Shih S, Shende A, et al. Cure of implantable venous port-associated bloodstream infections in pediatric hematology-oncology patients without catheter removal. Clin Infect Dis 1999 Jul; 29(1): 102–5PubMedCrossRef
112.
go back to reference Fowler Jr VG, Li J, Corey GR, et al. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol 1997 Oct; 30(4): 1072–8PubMedCrossRef Fowler Jr VG, Li J, Corey GR, et al. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol 1997 Oct; 30(4): 1072–8PubMedCrossRef
113.
go back to reference Rosen AB, Fowler Jr VG, Corey GR, et al. Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia. Ann Intern Med 1999 May 18; 130(10): 810–20PubMed Rosen AB, Fowler Jr VG, Corey GR, et al. Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia. Ann Intern Med 1999 May 18; 130(10): 810–20PubMed
114.
go back to reference Fowler Jr VG, Olsen MK, Corey GR, et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 2003 Sep 22; 163(17): 2066–72PubMedCrossRef Fowler Jr VG, Olsen MK, Corey GR, et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 2003 Sep 22; 163(17): 2066–72PubMedCrossRef
115.
go back to reference Raad II, Sabbagh MF. Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: a study of 55 cases and review. Clin Infect Dis 1992 Jan; 14(1): 75–82PubMedCrossRef Raad II, Sabbagh MF. Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: a study of 55 cases and review. Clin Infect Dis 1992 Jan; 14(1): 75–82PubMedCrossRef
116.
go back to reference Malanoski GJ, Samore MH, Pefanis A, et al. Staphylococcus aureus catheter-associated bacteremia: minimal effective therapy and unusual infectious complications associated with arterial sheath catheters. Arch Intern Med 1995 Jun 12; 155(11): 1161–6PubMedCrossRef Malanoski GJ, Samore MH, Pefanis A, et al. Staphylococcus aureus catheter-associated bacteremia: minimal effective therapy and unusual infectious complications associated with arterial sheath catheters. Arch Intern Med 1995 Jun 12; 155(11): 1161–6PubMedCrossRef
117.
go back to reference Rahal JJ. Preventing second-generation complications due to Staphylococcus aureus. Arch Intern Med 1989 Mar; 149(3): 503–4PubMedCrossRef Rahal JJ. Preventing second-generation complications due to Staphylococcus aureus. Arch Intern Med 1989 Mar; 149(3): 503–4PubMedCrossRef
118.
go back to reference Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995 Feb; 16(2): 105–13CrossRef Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995 Feb; 16(2): 105–13CrossRef
119.
go back to reference Peters G, Becker K. Epidemiology, control and treatment of methicillin-resistant Staphylococcus aureus. Drugs 1996; 52 Suppl. 2: 50–4PubMedCrossRef Peters G, Becker K. Epidemiology, control and treatment of methicillin-resistant Staphylococcus aureus. Drugs 1996; 52 Suppl. 2: 50–4PubMedCrossRef
120.
go back to reference Levine DP, Fromm BS, Reddy BR. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med 1991 Nov 1; 115(9): 674–80PubMed Levine DP, Fromm BS, Reddy BR. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med 1991 Nov 1; 115(9): 674–80PubMed
121.
go back to reference Jantausch BA, Deville J, Adler S, et al. Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens. Pediatr Infect Dis J 2003 Sep; 22 (9 Suppl.): S164–71PubMedCrossRef Jantausch BA, Deville J, Adler S, et al. Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens. Pediatr Infect Dis J 2003 Sep; 22 (9 Suppl.): S164–71PubMedCrossRef
122.
go back to reference Vaudaux P, Francois P, Bisognano C, et al. Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002 May; 46(5): 1503–9PubMedCrossRef Vaudaux P, Francois P, Bisognano C, et al. Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002 May; 46(5): 1503–9PubMedCrossRef
123.
go back to reference Chuard C, Herrmann M, Vaudaux P, et al. Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations. Antimicrob Agents Chemother 1991 Dec; 35(12): 2611–6PubMedCrossRef Chuard C, Herrmann M, Vaudaux P, et al. Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations. Antimicrob Agents Chemother 1991 Dec; 35(12): 2611–6PubMedCrossRef
124.
go back to reference Cagni A, Chuard C, Vaudaux PE, et al. Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1995 Aug; 39(8): 1655–60PubMedCrossRef Cagni A, Chuard C, Vaudaux PE, et al. Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1995 Aug; 39(8): 1655–60PubMedCrossRef
125.
go back to reference Schaad HJ, Chuard C, Vaudaux P, et al. Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1994 Aug; 38(8): 1703–10PubMedCrossRef Schaad HJ, Chuard C, Vaudaux P, et al. Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1994 Aug; 38(8): 1703–10PubMedCrossRef
126.
go back to reference Schaad HJ, Chuard C, Vaudaux P, et al. Comparative efficacies of imipenem, oxacillin and vancomycin for therapy of chronic foreign body infection due to methicillin-susceptible and -resistant Staphylococcus aureus. J Antimicrob Chemother 1994 Jun; 33(6): 1191–200PubMedCrossRef Schaad HJ, Chuard C, Vaudaux P, et al. Comparative efficacies of imipenem, oxacillin and vancomycin for therapy of chronic foreign body infection due to methicillin-susceptible and -resistant Staphylococcus aureus. J Antimicrob Chemother 1994 Jun; 33(6): 1191–200PubMedCrossRef
127.
go back to reference Rupp ME, Ulphani J. Efficacy of LY333328 in a rat model of Staphylococcus aureus central venous catheter-associated infection [abstract no. F111]. Programs and Abstracts of the Thirty-Eighth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, 1998. Washington, DC: American Society for Microbiology, 1998: 260 Rupp ME, Ulphani J. Efficacy of LY333328 in a rat model of Staphylococcus aureus central venous catheter-associated infection [abstract no. F111]. Programs and Abstracts of the Thirty-Eighth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, 1998. Washington, DC: American Society for Microbiology, 1998: 260
128.
go back to reference Vaudaux P, Francois P, Bisognano C, et al. Comparative efficacy of daptomycin and vancomycin in the therapy of experimental foreign body infection due to Staphylococcus aureus. J Antimicrob Chemother 2003 Jul; 52(1): 89–95PubMedCrossRef Vaudaux P, Francois P, Bisognano C, et al. Comparative efficacy of daptomycin and vancomycin in the therapy of experimental foreign body infection due to Staphylococcus aureus. J Antimicrob Chemother 2003 Jul; 52(1): 89–95PubMedCrossRef
129.
go back to reference Van Wijngaerden E, Peetermans WE, Vandersmissen J, et al. Foreign body infection: a new rat model for prophylaxis and treatment. J Antimicrob Chemother 1999 Nov; 44(5): 669–74PubMedCrossRef Van Wijngaerden E, Peetermans WE, Vandersmissen J, et al. Foreign body infection: a new rat model for prophylaxis and treatment. J Antimicrob Chemother 1999 Nov; 44(5): 669–74PubMedCrossRef
130.
go back to reference Rupp ME, Fey PD, Longo GM. Effect of LY333328 against vancomycin-resistant Enterococcus faecium in a rat central venous catheter-associated infection model. J Antimicrob Chemother 2001 May; 47(5): 705–7PubMedCrossRef Rupp ME, Fey PD, Longo GM. Effect of LY333328 against vancomycin-resistant Enterococcus faecium in a rat central venous catheter-associated infection model. J Antimicrob Chemother 2001 May; 47(5): 705–7PubMedCrossRef
131.
go back to reference Kuklin NA, Pancari GD, Tobery TW, et al. Real-time monitoring of bacterial infection in vivo: development of bioluminescent staphylococcal foreign-body and deep-thigh-wound mouse infection models. Antimicrob Agents Chemother 2003 Sep; 47(9): 2740–8PubMedCrossRef Kuklin NA, Pancari GD, Tobery TW, et al. Real-time monitoring of bacterial infection in vivo: development of bioluminescent staphylococcal foreign-body and deep-thigh-wound mouse infection models. Antimicrob Agents Chemother 2003 Sep; 47(9): 2740–8PubMedCrossRef
132.
go back to reference Swanson DS. Central venous catheter-related infections due to nontuberculous Mycobacterium species. Pediatr Infect Dis J 1998 Dec; 17(12): 1163–4PubMedCrossRef Swanson DS. Central venous catheter-related infections due to nontuberculous Mycobacterium species. Pediatr Infect Dis J 1998 Dec; 17(12): 1163–4PubMedCrossRef
133.
go back to reference Guay DR. Nontuberculous mycobacterial infections. Ann Pharmacother 1996 Jul; 30(7–8): 819–30PubMed Guay DR. Nontuberculous mycobacterial infections. Ann Pharmacother 1996 Jul; 30(7–8): 819–30PubMed
134.
go back to reference Ishida H, Ishida Y, Kurosaka Y, et al. In vitro and in vivo activities of levofloxacin against biofilm-producing Pseudomonas aeruginosa. Antimicrob Agents Chemother 1998 Jul; 42(7): 1641–5PubMed Ishida H, Ishida Y, Kurosaka Y, et al. In vitro and in vivo activities of levofloxacin against biofilm-producing Pseudomonas aeruginosa. Antimicrob Agents Chemother 1998 Jul; 42(7): 1641–5PubMed
135.
go back to reference Ashby MJ, Neale JE, Knott SJ, et al. Effect of antibiotics on non-growing planktonic cells and biofilms of Escherichia coli. J Antimicrob Chemother 1994 Mar; 33(3): 443–52PubMedCrossRef Ashby MJ, Neale JE, Knott SJ, et al. Effect of antibiotics on non-growing planktonic cells and biofilms of Escherichia coli. J Antimicrob Chemother 1994 Mar; 33(3): 443–52PubMedCrossRef
136.
go back to reference Gill MV, Ly H, Mueenuddin M, et al. Intravenous line infection due to Ochrobactrum anthropi (CDC Group Vd) in a normal host. Heart Lung 1997 Jul; 26(4): 335–6PubMedCrossRef Gill MV, Ly H, Mueenuddin M, et al. Intravenous line infection due to Ochrobactrum anthropi (CDC Group Vd) in a normal host. Heart Lung 1997 Jul; 26(4): 335–6PubMedCrossRef
137.
go back to reference Seifert H. Catheter-related infections due to gram-negative bacilli. In: Seifert H, Jansen B, Farr BM, editors. Catheter-related infections. New York: Marcel Dekker, 1997: 111–38 Seifert H. Catheter-related infections due to gram-negative bacilli. In: Seifert H, Jansen B, Farr BM, editors. Catheter-related infections. New York: Marcel Dekker, 1997: 111–38
138.
139.
go back to reference Hazen KC. New and emerging yeast pathogens. Clin Microbiol Rev 1995 Oct; 8(4): 462–78PubMed Hazen KC. New and emerging yeast pathogens. Clin Microbiol Rev 1995 Oct; 8(4): 462–78PubMed
140.
go back to reference Sizun J, Karangwa A, Giroux JD, et al. Malassezia furfur-related colonization and infection of central venous catheters: a prospective study in a pediatric intensive care unit. Intensive Care Med 1994 Aug; 20(7): 496–9PubMedCrossRef Sizun J, Karangwa A, Giroux JD, et al. Malassezia furfur-related colonization and infection of central venous catheters: a prospective study in a pediatric intensive care unit. Intensive Care Med 1994 Aug; 20(7): 496–9PubMedCrossRef
141.
go back to reference Anaissie EJ, Rex JH, Uzun Ö, et al. Predictors of adverse outcome in cancer patients with candidemia. Am J Med 1998 Mar; 104(3): 238–45PubMedCrossRef Anaissie EJ, Rex JH, Uzun Ö, et al. Predictors of adverse outcome in cancer patients with candidemia. Am J Med 1998 Mar; 104(3): 238–45PubMedCrossRef
142.
go back to reference Pappas PG, Rex JH, Sobel JD, et al. Guidelines for treatment of candidiasis. Clin Infect Dis 2004 Jan 15; 38(2): 161–89PubMedCrossRef Pappas PG, Rex JH, Sobel JD, et al. Guidelines for treatment of candidiasis. Clin Infect Dis 2004 Jan 15; 38(2): 161–89PubMedCrossRef
143.
go back to reference Karlowicz MG, Hashimoto LN, Kelly Jr RE, et al. Should central venous catheters be removed as soon as candidemia is detected in neonates? Pediatrics 2000 Nov; 106(5): E63PubMedCrossRef Karlowicz MG, Hashimoto LN, Kelly Jr RE, et al. Should central venous catheters be removed as soon as candidemia is detected in neonates? Pediatrics 2000 Nov; 106(5): E63PubMedCrossRef
144.
go back to reference Munoz P, Burillo A, Bouza E. Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit. Int J Antimicrob Agents 2000 Jul; 15(2): 83–90CrossRef Munoz P, Burillo A, Bouza E. Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit. Int J Antimicrob Agents 2000 Jul; 15(2): 83–90CrossRef
145.
go back to reference Rex JH, Walsh TJ, Sobel JD, et al. Practice guidelines for the treatment of candidiasis: Infectious Diseases Society of America. Clin Infect Dis 2000 Apr; 30(4): 662–78PubMedCrossRef Rex JH, Walsh TJ, Sobel JD, et al. Practice guidelines for the treatment of candidiasis: Infectious Diseases Society of America. Clin Infect Dis 2000 Apr; 30(4): 662–78PubMedCrossRef
146.
go back to reference Kibbler CC, Seaton S, Barnes RA, et al. Management and outcome of bloodstream infections due to Candida species in England and Wales. J Hosp Infect 2003 May; 54(1): 18–24PubMedCrossRef Kibbler CC, Seaton S, Barnes RA, et al. Management and outcome of bloodstream infections due to Candida species in England and Wales. J Hosp Infect 2003 May; 54(1): 18–24PubMedCrossRef
147.
go back to reference Nguyen MH, Peacock Jr JE, Tanner DC, et al. Therapeutic approaches in patients with candidemia: evaluation in a multicenter, prospective, observational study. Arch Intern Med 1995 Dec 11; 155(22): 2429–35PubMedCrossRef Nguyen MH, Peacock Jr JE, Tanner DC, et al. Therapeutic approaches in patients with candidemia: evaluation in a multicenter, prospective, observational study. Arch Intern Med 1995 Dec 11; 155(22): 2429–35PubMedCrossRef
148.
go back to reference Lecciones JA, Lee JW, Navarro EE, et al. Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin Infect Dis 1992 Apr; 14(4): 875–83PubMedCrossRef Lecciones JA, Lee JW, Navarro EE, et al. Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin Infect Dis 1992 Apr; 14(4): 875–83PubMedCrossRef
149.
150.
go back to reference Barber GR, Brown AE, Kiehn TE, et al. Catheter-related Malassezia furfur fungemia in immunocompromised patients. Am J Med 1993 Oct; 95(4): 365–70PubMedCrossRef Barber GR, Brown AE, Kiehn TE, et al. Catheter-related Malassezia furfur fungemia in immunocompromised patients. Am J Med 1993 Oct; 95(4): 365–70PubMedCrossRef
151.
go back to reference Ostrosky-Zeichner L, Marr KA, Rex JH, et al. Amphotericin B: time for a new ‘gold standard’. Clin Infect Dis 2003 Aug 1; 37(3): 415–25PubMedCrossRef Ostrosky-Zeichner L, Marr KA, Rex JH, et al. Amphotericin B: time for a new ‘gold standard’. Clin Infect Dis 2003 Aug 1; 37(3): 415–25PubMedCrossRef
152.
go back to reference Rex JH, Bennett JE, Sugar AM, et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia: Candidemia Study Group and the National Institute. N Engl J Med 1994 Nov 17; 331(20): 1325–30PubMedCrossRef Rex JH, Bennett JE, Sugar AM, et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia: Candidemia Study Group and the National Institute. N Engl J Med 1994 Nov 17; 331(20): 1325–30PubMedCrossRef
153.
go back to reference Diekema DJ, Messer SA, Hollis RJ, et al. Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi. J Clin Microbiol 2003 Aug; 41(8): 3623–6PubMedCrossRef Diekema DJ, Messer SA, Hollis RJ, et al. Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi. J Clin Microbiol 2003 Aug; 41(8): 3623–6PubMedCrossRef
154.
go back to reference Mora-Duarte J, Betts R, Rotstein C, et al. Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 2002 Dec 19; 347(25): 2020–9PubMedCrossRef Mora-Duarte J, Betts R, Rotstein C, et al. Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 2002 Dec 19; 347(25): 2020–9PubMedCrossRef
155.
go back to reference Kauffman CA, Zarins LT. In vitro activity of voriconazole against Candida species. Diagn Microbiol Infect Dis 1998 May; 31(1): 297–300PubMedCrossRef Kauffman CA, Zarins LT. In vitro activity of voriconazole against Candida species. Diagn Microbiol Infect Dis 1998 May; 31(1): 297–300PubMedCrossRef
156.
go back to reference Fegeler W, Bille J, Dupont B, et al. Distribution of yeast species in clinical routine diagnostic specimen and their susceptibility to fluconazole, voriconazole and flucytosine. Mycoses 1999; 42: 174–5 Fegeler W, Bille J, Dupont B, et al. Distribution of yeast species in clinical routine diagnostic specimen and their susceptibility to fluconazole, voriconazole and flucytosine. Mycoses 1999; 42: 174–5
157.
go back to reference Patron RL, Climo MW, Goldstein BP, et al. Lysostaphin treatment of experimental aortic valve endocarditis caused by a Staphylococcus aureus isolate with reduced susceptibility to vancomycin. Antimicrob Agents Chemother 1999 Jul; 43(7): 1754–5PubMed Patron RL, Climo MW, Goldstein BP, et al. Lysostaphin treatment of experimental aortic valve endocarditis caused by a Staphylococcus aureus isolate with reduced susceptibility to vancomycin. Antimicrob Agents Chemother 1999 Jul; 43(7): 1754–5PubMed
158.
go back to reference von Eiff C, Kokai-Kun JF, Becker K, et al. In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from anterior nares and blood. Antimicrob Agents Chemother 2003 Nov; 47(11): 3613–5CrossRef von Eiff C, Kokai-Kun JF, Becker K, et al. In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from anterior nares and blood. Antimicrob Agents Chemother 2003 Nov; 47(11): 3613–5CrossRef
159.
go back to reference Wu JA, Kusuma C, Mond JJ, et al. Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces. Antimicrob Agents Chemother 2003 Nov; 47(11): 3407–14PubMedCrossRef Wu JA, Kusuma C, Mond JJ, et al. Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces. Antimicrob Agents Chemother 2003 Nov; 47(11): 3407–14PubMedCrossRef
160.
go back to reference Johansen C, Falholt P, Gram L. Enzymatic removal and disinfection of bacterial biofilms. Appl Environ Microbiol 1997 Sep; 63(9): 3724–8PubMed Johansen C, Falholt P, Gram L. Enzymatic removal and disinfection of bacterial biofilms. Appl Environ Microbiol 1997 Sep; 63(9): 3724–8PubMed
161.
go back to reference Dewhurst E, Rawson DM, Steele GC. The use of a model system to compare the efficiency of ultrasound and agitation in the recovery of Bacillus subtilis spores from polymer surfaces. J Appl Bacteriol 1986 Oct; 61(4): 357–63PubMedCrossRef Dewhurst E, Rawson DM, Steele GC. The use of a model system to compare the efficiency of ultrasound and agitation in the recovery of Bacillus subtilis spores from polymer surfaces. J Appl Bacteriol 1986 Oct; 61(4): 357–63PubMedCrossRef
162.
go back to reference Carmen JC, Roeder BL, Nelson JL, et al. Ultrasonically enhanced vancomycin activity against Staphylococcus epidermidis biofilms in vivo. J Biomater Appl 2004 Apr; 18(4): 237–45PubMedCrossRef Carmen JC, Roeder BL, Nelson JL, et al. Ultrasonically enhanced vancomycin activity against Staphylococcus epidermidis biofilms in vivo. J Biomater Appl 2004 Apr; 18(4): 237–45PubMedCrossRef
163.
go back to reference Rediske AM, Roeder BL, Nelson JL, et al. Pulsed ultrasound enhances the killing of Escherichia coli biofilms by aminoglycoside antibiotics in vivo. Antimicrob Agents Chemother 2000 Mar; 44(3): 771–2PubMedCrossRef Rediske AM, Roeder BL, Nelson JL, et al. Pulsed ultrasound enhances the killing of Escherichia coli biofilms by aminoglycoside antibiotics in vivo. Antimicrob Agents Chemother 2000 Mar; 44(3): 771–2PubMedCrossRef
164.
go back to reference Pitt WG, Ross SA. Ultrasound increases the rate of bacterial cell growth. Biotechnol Prog 2003 May; 19(3): 1038–44PubMedCrossRef Pitt WG, Ross SA. Ultrasound increases the rate of bacterial cell growth. Biotechnol Prog 2003 May; 19(3): 1038–44PubMedCrossRef
165.
go back to reference Rosenthal VD, Guzman S, Pezzotto SM, et al. Effect of an infection control program using education and performance feedback on rates of intravascular device-associated bloodstream infections in intensive care units in Argentina. Am J Infect Control 2003 Nov; 31(7): 405–9PubMedCrossRef Rosenthal VD, Guzman S, Pezzotto SM, et al. Effect of an infection control program using education and performance feedback on rates of intravascular device-associated bloodstream infections in intensive care units in Argentina. Am J Infect Control 2003 Nov; 31(7): 405–9PubMedCrossRef
166.
go back to reference Sherertz RJ, Ely EW, Westbrook DM, et al. Education of physicians-in-training can decrease the risk for vascular catheter infection. Ann Intern Med 2000 Apr 18; 132(8): 641–8PubMed Sherertz RJ, Ely EW, Westbrook DM, et al. Education of physicians-in-training can decrease the risk for vascular catheter infection. Ann Intern Med 2000 Apr 18; 132(8): 641–8PubMed
167.
go back to reference Eggimann P, Harbarth S, Constantin MN, et al. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 2000 May 27; 355(9218): 1864–8PubMedCrossRef Eggimann P, Harbarth S, Constantin MN, et al. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 2000 May 27; 355(9218): 1864–8PubMedCrossRef
168.
go back to reference Soifer NE, Borzak S, Edlin BR, et al. Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med 1998 Mar 9; 158(5): 473–7PubMedCrossRef Soifer NE, Borzak S, Edlin BR, et al. Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med 1998 Mar 9; 158(5): 473–7PubMedCrossRef
169.
go back to reference Fridkin SK, Pear SM, Williamson TH, et al. The role of understaffing in central venous catheter-associated bloodstream infections. Infect Control Hosp Epidemiol 1996 Mar; 17(3): 150–8PubMedCrossRef Fridkin SK, Pear SM, Williamson TH, et al. The role of understaffing in central venous catheter-associated bloodstream infections. Infect Control Hosp Epidemiol 1996 Mar; 17(3): 150–8PubMedCrossRef
170.
go back to reference Bertone SA, Fisher MC, Mortensen JE. Quantitative skin cultures at potential catheter sites in neonates. Infect Control Hosp Epidemiol 1994 May; 15(5): 315–8PubMedCrossRef Bertone SA, Fisher MC, Mortensen JE. Quantitative skin cultures at potential catheter sites in neonates. Infect Control Hosp Epidemiol 1994 May; 15(5): 315–8PubMedCrossRef
171.
go back to reference Goetz AM, Wagener MM, Miller JM, et al. Risk of infection due to central venous catheters: effect of site of placement and catheter type. Infect Control Hosp Epidemiol 1998 Nov; 19(11): 842–5PubMedCrossRef Goetz AM, Wagener MM, Miller JM, et al. Risk of infection due to central venous catheters: effect of site of placement and catheter type. Infect Control Hosp Epidemiol 1998 Nov; 19(11): 842–5PubMedCrossRef
172.
go back to reference Randolph AG, Cook DJ, Gonzales CA, et al. Ultrasound guidance for placement of central venous catheters: a metaanalysis of the literature. Crit Care Med 1996 Dec; 24(12): 2053–8PubMedCrossRef Randolph AG, Cook DJ, Gonzales CA, et al. Ultrasound guidance for placement of central venous catheters: a metaanalysis of the literature. Crit Care Med 1996 Dec; 24(12): 2053–8PubMedCrossRef
173.
go back to reference Heard SO, Wagle M, Vijayakumar E, et al. Influence of triplelumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Arch Intern Med 1998 Jan 12; 158(1): 81–7PubMedCrossRef Heard SO, Wagle M, Vijayakumar E, et al. Influence of triplelumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Arch Intern Med 1998 Jan 12; 158(1): 81–7PubMedCrossRef
174.
go back to reference Richet H, Hubert B, Nitemberg G, et al. Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients. J Clin Microbiol 1990 Nov; 28(11): 2520–5PubMed Richet H, Hubert B, Nitemberg G, et al. Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients. J Clin Microbiol 1990 Nov; 28(11): 2520–5PubMed
175.
go back to reference Merrer J, De Jonghe B, Golliot F, et al. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA 2001 Aug 8; 286(6): 700–7PubMedCrossRef Merrer J, De Jonghe B, Golliot F, et al. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA 2001 Aug 8; 286(6): 700–7PubMedCrossRef
176.
go back to reference Maki DG, Mermel LA. Infections due to infusion therapy. In: Bennett JV, Brachmann PS, editors. Hospital infections. Philadelphia (PA): Lippincott-Raven, 1998: 689–724 Maki DG, Mermel LA. Infections due to infusion therapy. In: Bennett JV, Brachmann PS, editors. Hospital infections. Philadelphia (PA): Lippincott-Raven, 1998: 689–724
177.
go back to reference MacDonald A, Dinah F, Mackenzie D, et al. Performance feedback of hand hygiene, using alcohol gel as the skin decontaminant, reduces the number of inpatients newly affected by MRSA and antibiotic costs. J Hosp Infect 2004 Jan; 56(1): 56–63PubMedCrossRef MacDonald A, Dinah F, Mackenzie D, et al. Performance feedback of hand hygiene, using alcohol gel as the skin decontaminant, reduces the number of inpatients newly affected by MRSA and antibiotic costs. J Hosp Infect 2004 Jan; 56(1): 56–63PubMedCrossRef
178.
go back to reference Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene: Infection Control Programme. Lancet 2000 Oct 14; 356(9238): 1307–12PubMedCrossRef Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene: Infection Control Programme. Lancet 2000 Oct 14; 356(9238): 1307–12PubMedCrossRef
179.
go back to reference Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994 Apr; 15 (4 Pt 1): 231–8PubMedCrossRef Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994 Apr; 15 (4 Pt 1): 231–8PubMedCrossRef
180.
go back to reference Galway R, Harrod ME, Crisp J, et al. Central venous access and handwashing: variability in policies and practices. Paediatr Nurs 2003 Dec; 15(10): 14–8PubMed Galway R, Harrod ME, Crisp J, et al. Central venous access and handwashing: variability in policies and practices. Paediatr Nurs 2003 Dec; 15(10): 14–8PubMed
181.
go back to reference Boyce JM, Pittet D. Guideline for Hand Hygiene in Health-Care Settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/ IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm Rep 2002 Oct 25; 51(RR-16): 1–45PubMed Boyce JM, Pittet D. Guideline for Hand Hygiene in Health-Care Settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/ IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm Rep 2002 Oct 25; 51(RR-16): 1–45PubMed
182.
go back to reference Safdar N, Maki DG. The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med 2004 Jan; 30(1): 62–7PubMedCrossRef Safdar N, Maki DG. The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med 2004 Jan; 30(1): 62–7PubMedCrossRef
183.
go back to reference Clemence MA, Walker D, Farr BM. Central venous catheter practices: results of a survey. Am J Infect Control 1995 Feb; 23(1): 5–12PubMedCrossRef Clemence MA, Walker D, Farr BM. Central venous catheter practices: results of a survey. Am J Infect Control 1995 Feb; 23(1): 5–12PubMedCrossRef
184.
go back to reference Humar A, Ostromecki A, Direnfeld J, et al. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection. Clin Infect Dis 2000 Oct; 31(4): 1001–7PubMedCrossRef Humar A, Ostromecki A, Direnfeld J, et al. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection. Clin Infect Dis 2000 Oct; 31(4): 1001–7PubMedCrossRef
185.
go back to reference Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991 Aug 10; 338(8763): 339–43PubMedCrossRef Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991 Aug 10; 338(8763): 339–43PubMedCrossRef
186.
go back to reference Garland JS, Buck RK, Maloney P, et al. Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: a prospective trial. Pediatr Infect Dis J 1995 Jun; 14(6): 510–6PubMedCrossRef Garland JS, Buck RK, Maloney P, et al. Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: a prospective trial. Pediatr Infect Dis J 1995 Jun; 14(6): 510–6PubMedCrossRef
187.
go back to reference Maki DG, Ringer M. Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters: gauze, a transparent polyurethane dressing, and an iodophortransparent dressing. JAMA 1987 Nov 6; 258(17): 2396–403PubMedCrossRef Maki DG, Ringer M. Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters: gauze, a transparent polyurethane dressing, and an iodophortransparent dressing. JAMA 1987 Nov 6; 258(17): 2396–403PubMedCrossRef
188.
go back to reference Hoffmann KK, Weber DJ, Samsa GP, et al. Transparent polyurethane film as an intravenous catheter dressing: a metaanalysis of the infection risks. JAMA 1992 Apr 15; 267(15): 2072–6PubMedCrossRef Hoffmann KK, Weber DJ, Samsa GP, et al. Transparent polyurethane film as an intravenous catheter dressing: a metaanalysis of the infection risks. JAMA 1992 Apr 15; 267(15): 2072–6PubMedCrossRef
189.
go back to reference Maki DG, Mermel LA, Kluger DM. The efficacy of a chlorhexidine-impregnated sponge (biopatch) for the prevention of intravascular catheter-related infection: a prospective, randomized, controlled, multicenter trial [abstract no. 1430]. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy of the American Society for Microbiology; 2000 Sep 17–20; Toronto Maki DG, Mermel LA, Kluger DM. The efficacy of a chlorhexidine-impregnated sponge (biopatch) for the prevention of intravascular catheter-related infection: a prospective, randomized, controlled, multicenter trial [abstract no. 1430]. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy of the American Society for Microbiology; 2000 Sep 17–20; Toronto
190.
go back to reference Yamamoto AJ, Solomon JA, Soulen MC, et al. Sutureless securement device reduces complications of peripherally inserted central venous catheters. J Vasc Interv Radiol 2002 Jan; 13(1): 77–81PubMedCrossRef Yamamoto AJ, Solomon JA, Soulen MC, et al. Sutureless securement device reduces complications of peripherally inserted central venous catheters. J Vasc Interv Radiol 2002 Jan; 13(1): 77–81PubMedCrossRef
191.
go back to reference Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters: a randomized controlled trial. Ann Intern Med 1991 May 15; 114(10): 845–54PubMed Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters: a randomized controlled trial. Ann Intern Med 1991 May 15; 114(10): 845–54PubMed
192.
go back to reference Tully JL, Friedland GH, Baldini LM, et al. Complications of intravenous therapy with steel needles and Teflon catheters: a comparative study. Am J Med 1981 Mar; 70(3): 702–6PubMedCrossRef Tully JL, Friedland GH, Baldini LM, et al. Complications of intravenous therapy with steel needles and Teflon catheters: a comparative study. Am J Med 1981 Mar; 70(3): 702–6PubMedCrossRef
193.
go back to reference Ball PA. Intravenous in-line filters: filtering the evidence. Curr Opin Clin Nutr Metab Care 2003 May; 6(3): 319–25PubMed Ball PA. Intravenous in-line filters: filtering the evidence. Curr Opin Clin Nutr Metab Care 2003 May; 6(3): 319–25PubMed
194.
go back to reference Maddox RR, John Jr JF, Brown LL, et al. Effect of inline filtration on postinfusion phlebitis. Clin Pharm 1983 Jan; 2(1): 58–61PubMed Maddox RR, John Jr JF, Brown LL, et al. Effect of inline filtration on postinfusion phlebitis. Clin Pharm 1983 Jan; 2(1): 58–61PubMed
195.
go back to reference Ascher DP, Shoupe BA, Maybee D, et al. Persistent catheter-related bacteremia: clearance with antibiotics and urokinase. J Pediatr Surg 1993 Apr; 28(4): 627–9PubMedCrossRef Ascher DP, Shoupe BA, Maybee D, et al. Persistent catheter-related bacteremia: clearance with antibiotics and urokinase. J Pediatr Surg 1993 Apr; 28(4): 627–9PubMedCrossRef
196.
go back to reference Khoury AE, Lam K, Ellis B, et al. Prevention and control of bacterial infections associated with medical devices. ASAIO J 1992 Jul; 38(3): M174–8PubMedCrossRef Khoury AE, Lam K, Ellis B, et al. Prevention and control of bacterial infections associated with medical devices. ASAIO J 1992 Jul; 38(3): M174–8PubMedCrossRef
197.
go back to reference Rediske AM, Roeder BL, Brown MK, et al. Ultrasonic enhancement of antibiotic action on Escherichia coli biofilms: an in vivo model. Antimicrob Agents Chemother 1999 May; 43(5): 1211–4PubMed Rediske AM, Roeder BL, Brown MK, et al. Ultrasonic enhancement of antibiotic action on Escherichia coli biofilms: an in vivo model. Antimicrob Agents Chemother 1999 May; 43(5): 1211–4PubMed
198.
go back to reference Bridgett MJ, Davies MC, Denyer SP. Control of staphylococcal adhesion to polystyrene surfaces by polymer surface modification with surfactants. Biomaterials 1992; 13(7): 411–6PubMedCrossRef Bridgett MJ, Davies MC, Denyer SP. Control of staphylococcal adhesion to polystyrene surfaces by polymer surface modification with surfactants. Biomaterials 1992; 13(7): 411–6PubMedCrossRef
199.
go back to reference Desai NP, Hossainy SF, Hubbell JA. Surface-immobilized polyethylene oxide for bacterial repellence. Biomaterials 1992; 13(7): 417–20PubMedCrossRef Desai NP, Hossainy SF, Hubbell JA. Surface-immobilized polyethylene oxide for bacterial repellence. Biomaterials 1992; 13(7): 417–20PubMedCrossRef
200.
go back to reference Dunkirk SG, Gregg SL, Duran LW, et al. Photochemical coatings for the prevention of bacterial colonization. J Biomater Appl 1991 Oct; 6(2): 131–56PubMedCrossRef Dunkirk SG, Gregg SL, Duran LW, et al. Photochemical coatings for the prevention of bacterial colonization. J Biomater Appl 1991 Oct; 6(2): 131–56PubMedCrossRef
201.
go back to reference Tebbs SE, Sawyer A, Elliott TS. Influence of surface morphology on in vitro bacterial adherence to central venous catheters. Br J Anaesth 1994 May; 72(5): 587–91PubMedCrossRef Tebbs SE, Sawyer A, Elliott TS. Influence of surface morphology on in vitro bacterial adherence to central venous catheters. Br J Anaesth 1994 May; 72(5): 587–91PubMedCrossRef
202.
go back to reference Tebbs SE, Elliott TS. Modification of central venous catheter polymers to prevent in vitro microbial colonisation. Eur J Clin Microbiol Infect Dis 1994 Feb; 13(2): 111–7PubMedCrossRef Tebbs SE, Elliott TS. Modification of central venous catheter polymers to prevent in vitro microbial colonisation. Eur J Clin Microbiol Infect Dis 1994 Feb; 13(2): 111–7PubMedCrossRef
203.
go back to reference Jansen B. New concepts in the prevention of polymer-associated foreign body infections. Zentralbl Bakteriol 1990 Apr; 272(4): 401–10PubMedCrossRef Jansen B. New concepts in the prevention of polymer-associated foreign body infections. Zentralbl Bakteriol 1990 Apr; 272(4): 401–10PubMedCrossRef
204.
go back to reference Jansen B, Schareina S, Steinhauser H, et al. Development of polymers with antiinfective properties. Polym Mater Sci Eng 1987; 57: 43–6 Jansen B, Schareina S, Steinhauser H, et al. Development of polymers with antiinfective properties. Polym Mater Sci Eng 1987; 57: 43–6
205.
go back to reference Han DK, Park KD, Kim YH. Sulfonated poly (ethylene oxide)-grafted polyurethane copolymer for biomedical applications. J Biomater Sci Polym Ed 1998; 9(2): 163–74PubMedCrossRef Han DK, Park KD, Kim YH. Sulfonated poly (ethylene oxide)-grafted polyurethane copolymer for biomedical applications. J Biomater Sci Polym Ed 1998; 9(2): 163–74PubMedCrossRef
206.
go back to reference Baumgartner JN, Yang CZ, Cooper SL. Physical property analysis and bacterial adhesion on a series of phosphonated polyurethanes. Biomaterials 1997 Jun; 18(12): 831–7PubMedCrossRef Baumgartner JN, Yang CZ, Cooper SL. Physical property analysis and bacterial adhesion on a series of phosphonated polyurethanes. Biomaterials 1997 Jun; 18(12): 831–7PubMedCrossRef
207.
go back to reference Kohnen W, Jansen B. Changing material surface chemistry for preventing bacterial adhesion. In: An YH, Friedman RJ, editors. Handbook of bacterial adhesion. Totowa (NJ): Humana Press, 2000: 581–9CrossRef Kohnen W, Jansen B. Changing material surface chemistry for preventing bacterial adhesion. In: An YH, Friedman RJ, editors. Handbook of bacterial adhesion. Totowa (NJ): Humana Press, 2000: 581–9CrossRef
208.
go back to reference An YH, Blair BK, Martin KL, et al. Macromolecule surface coating for preventing bacterial adhesion. In: YH An, Friedman RJ, editors. Handbook of bacterial adhesion. Totowa (NJ): Humana Press, 2000: 609–25CrossRef An YH, Blair BK, Martin KL, et al. Macromolecule surface coating for preventing bacterial adhesion. In: YH An, Friedman RJ, editors. Handbook of bacterial adhesion. Totowa (NJ): Humana Press, 2000: 609–25CrossRef
209.
go back to reference Jansen B, Kohnen W. Prevention of biofilm formation by polymer modification. J Ind Microbiol 1995 Oct; 15(4): 391–6PubMedCrossRef Jansen B, Kohnen W. Prevention of biofilm formation by polymer modification. J Ind Microbiol 1995 Oct; 15(4): 391–6PubMedCrossRef
210.
go back to reference Marcinko DE. Gentamicin-impregnated PMMA beads: an introduction and review. J Foot Surg 1985 Mar; 24(2): 116–21PubMed Marcinko DE. Gentamicin-impregnated PMMA beads: an introduction and review. J Foot Surg 1985 Mar; 24(2): 116–21PubMed
211.
go back to reference Welch A. Antibiotics in acrylic bone cement: in vitro studies. J Biomed Mater Res 1978 Sep; 12(5): 679–700PubMedCrossRef Welch A. Antibiotics in acrylic bone cement: in vitro studies. J Biomed Mater Res 1978 Sep; 12(5): 679–700PubMedCrossRef
212.
go back to reference Moore WS, Chvapil M, Seiffert G, et al. Development of an infection-resistant vascular prosthesis. Arch Surg 1981 Nov; 116(11): 1403–7PubMedCrossRef Moore WS, Chvapil M, Seiffert G, et al. Development of an infection-resistant vascular prosthesis. Arch Surg 1981 Nov; 116(11): 1403–7PubMedCrossRef
213.
go back to reference Powell TW, Burnham SJ, Johnson Jr G. A passive system using rifampin to create an infection-resistant vascular prosthesis. Surgery 1983 Nov; 94(5): 765–9PubMed Powell TW, Burnham SJ, Johnson Jr G. A passive system using rifampin to create an infection-resistant vascular prosthesis. Surgery 1983 Nov; 94(5): 765–9PubMed
214.
go back to reference McDougal EG, Burnham SJ, Johnson Jr G. Rifampin protection against experimental graft sepsis. J Vasc Surg 1986 Jul; 4(1): 5–7PubMed McDougal EG, Burnham SJ, Johnson Jr G. Rifampin protection against experimental graft sepsis. J Vasc Surg 1986 Jul; 4(1): 5–7PubMed
215.
go back to reference Solovskij MV, Ulbrich K, Kopecek J. Synthesis of N-(2-hydroxypropyl)methacrylamide copolymers with antimicrobial activity. Biomaterials 1983 Jan; 4(1): 44–8PubMedCrossRef Solovskij MV, Ulbrich K, Kopecek J. Synthesis of N-(2-hydroxypropyl)methacrylamide copolymers with antimicrobial activity. Biomaterials 1983 Jan; 4(1): 44–8PubMedCrossRef
216.
go back to reference Sherertz RJ, Carruth WA, Hampton AA, et al. Efficacy of antibiotic-coated catheters in preventing subcutaneous Staphylococcus aureus infection in rabbits. J Infect Dis 1993 Jan; 167(1): 98–106PubMedCrossRef Sherertz RJ, Carruth WA, Hampton AA, et al. Efficacy of antibiotic-coated catheters in preventing subcutaneous Staphylococcus aureus infection in rabbits. J Infect Dis 1993 Jan; 167(1): 98–106PubMedCrossRef
217.
go back to reference Jansen B, Peters G. Modern strategies in the prevention of polymer-associated infections. J Hosp Infect 1991 Oct; 19(2): 83–8PubMedCrossRef Jansen B, Peters G. Modern strategies in the prevention of polymer-associated infections. J Hosp Infect 1991 Oct; 19(2): 83–8PubMedCrossRef
218.
go back to reference Jansen B, Jansen S, Peters G, et al. In-vitro efficacy of a central venous catheter (‘Hydrocath’) loaded with teicoplanin to prevent bacterial colonization. J Hosp Infect 1992 Oct; 22(2): 93–107PubMedCrossRef Jansen B, Jansen S, Peters G, et al. In-vitro efficacy of a central venous catheter (‘Hydrocath’) loaded with teicoplanin to prevent bacterial colonization. J Hosp Infect 1992 Oct; 22(2): 93–107PubMedCrossRef
219.
go back to reference Romano G, Berti M, Goldstein BP, et al. Efficacy of a central venous catheter (Hydrocath) loaded with teicoplanin in preventing subcutaneous staphylococcal infection in the mouse. Zentralbl Bakteriol 1993 Aug; 279(3): 426–33PubMedCrossRef Romano G, Berti M, Goldstein BP, et al. Efficacy of a central venous catheter (Hydrocath) loaded with teicoplanin in preventing subcutaneous staphylococcal infection in the mouse. Zentralbl Bakteriol 1993 Aug; 279(3): 426–33PubMedCrossRef
220.
go back to reference Kamal GD, Pfaller MA, Rempe LE, et al. Reduced intravascular catheter infection by antibiotic bonding: a prospective, randomized, controlled trial. JAMA 1991 May 8; 265(18): 2364–8PubMedCrossRef Kamal GD, Pfaller MA, Rempe LE, et al. Reduced intravascular catheter infection by antibiotic bonding: a prospective, randomized, controlled trial. JAMA 1991 May 8; 265(18): 2364–8PubMedCrossRef
221.
go back to reference Kamal GD, Divishek D, Kumar GC, et al. Reduced intravascular catheter-related infection by routine use of antibiotic-bonded catheters in a surgical intensive care unit. Diagn Microbiol Infect Dis 1998 Mar; 30(3): 145–52PubMedCrossRef Kamal GD, Divishek D, Kumar GC, et al. Reduced intravascular catheter-related infection by routine use of antibiotic-bonded catheters in a surgical intensive care unit. Diagn Microbiol Infect Dis 1998 Mar; 30(3): 145–52PubMedCrossRef
222.
go back to reference Raad I, Darouiche R, Hachem R, et al. Antibiotics and prevention of microbial colonization of catheters. Antimicrob Agents Chemother 1995 Nov; 39(11): 2397–400PubMedCrossRef Raad I, Darouiche R, Hachem R, et al. Antibiotics and prevention of microbial colonization of catheters. Antimicrob Agents Chemother 1995 Nov; 39(11): 2397–400PubMedCrossRef
223.
go back to reference Raad I, Darouiche R, Hachem R, et al. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis 1996 Feb; 173(2): 418–24PubMedCrossRef Raad I, Darouiche R, Hachem R, et al. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis 1996 Feb; 173(2): 418–24PubMedCrossRef
224.
go back to reference Raad I, Darouiche R, Dupuis J, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med 1997 Aug 15; 127(4): 267–74 Raad I, Darouiche R, Dupuis J, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med 1997 Aug 15; 127(4): 267–74
225.
go back to reference Darouiche RO, Raad II, Heard SO, et al. A comparison of two antimicrobial-impregnated central venous catheters: Catheter Study Group. N Engl J Med 1999 Jan 7; 340(1): 1–8PubMedCrossRef Darouiche RO, Raad II, Heard SO, et al. A comparison of two antimicrobial-impregnated central venous catheters: Catheter Study Group. N Engl J Med 1999 Jan 7; 340(1): 1–8PubMedCrossRef
226.
go back to reference Crnich CJ, Maki DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I: pathogenesis and short-term devices. Clin Infect Dis 2002 May 1; 34(9): 1232–42 Crnich CJ, Maki DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I: pathogenesis and short-term devices. Clin Infect Dis 2002 May 1; 34(9): 1232–42
227.
go back to reference Tambe SM, Sampath L, Modak SM. In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices. J Antimicrob Chemother 2001 May; 47(5): 589–98PubMedCrossRef Tambe SM, Sampath L, Modak SM. In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices. J Antimicrob Chemother 2001 May; 47(5): 589–98PubMedCrossRef
228.
go back to reference Donelli G, Francolini I, Piozzi A, et al. New polymer-antibiotic systems to inhibit bacterial biofilm formation: a suitable approach to prevent central venous catheter-associated infections. J Chemother 2002 Oct; 14(5): 501–7PubMed Donelli G, Francolini I, Piozzi A, et al. New polymer-antibiotic systems to inhibit bacterial biofilm formation: a suitable approach to prevent central venous catheter-associated infections. J Chemother 2002 Oct; 14(5): 501–7PubMed
229.
go back to reference Schierholz JM, Fleck C, Beuth J, et al. The antimicrobial efficacy of a new central venous catheter with long-term broad-spectrum activity. J Antimicrob Chemother 2000 Jul; 46(1): 45–50PubMedCrossRef Schierholz JM, Fleck C, Beuth J, et al. The antimicrobial efficacy of a new central venous catheter with long-term broad-spectrum activity. J Antimicrob Chemother 2000 Jul; 46(1): 45–50PubMedCrossRef
230.
go back to reference Kingston D, Seal DV, Hill ID. Self-disinfecting plastics for intravenous catheters and prosthetic inserts. J Hyg (Lond) 1986 Apr; 96(2): 185–98CrossRef Kingston D, Seal DV, Hill ID. Self-disinfecting plastics for intravenous catheters and prosthetic inserts. J Hyg (Lond) 1986 Apr; 96(2): 185–98CrossRef
231.
go back to reference Quesnel LB, AI Najjar AR, Buddhavudhikrai P. Synergism between chlorhexidine and sulphadiazine. J Appl Bacteriol 1978 Dec; 45(3): 397–405PubMedCrossRef Quesnel LB, AI Najjar AR, Buddhavudhikrai P. Synergism between chlorhexidine and sulphadiazine. J Appl Bacteriol 1978 Dec; 45(3): 397–405PubMedCrossRef
232.
go back to reference Bach A, Schmidt H, Bottiger B, et al. Retention of antibacterial activity and bacterial colonization of antiseptic-bonded central venous catheters. J Antimicrob Chemother 1996 Feb; 37(2): 315–22PubMedCrossRef Bach A, Schmidt H, Bottiger B, et al. Retention of antibacterial activity and bacterial colonization of antiseptic-bonded central venous catheters. J Antimicrob Chemother 1996 Feb; 37(2): 315–22PubMedCrossRef
233.
go back to reference Hannan M, Juste RN, Umasanker S, et al. Antiseptic-bonded central venous catheters and bacterial colonisation. Anaesthesia 1999 Sep; 54(9): 868–72PubMedCrossRef Hannan M, Juste RN, Umasanker S, et al. Antiseptic-bonded central venous catheters and bacterial colonisation. Anaesthesia 1999 Sep; 54(9): 868–72PubMedCrossRef
234.
go back to reference Ciresi DL, Albrecht RM, Volkers PA, et al. Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis. Am Surg 1996 Aug; 62(8): 641–6PubMed Ciresi DL, Albrecht RM, Volkers PA, et al. Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis. Am Surg 1996 Aug; 62(8): 641–6PubMed
235.
go back to reference Pemberton LB, Ross V, Cuddy P, et al. No difference in catheter sepsis between standard and antiseptic central venous catheters: a prospective randomized trial. Arch Surg 1996 Sep; 131(9): 986–9PubMedCrossRef Pemberton LB, Ross V, Cuddy P, et al. No difference in catheter sepsis between standard and antiseptic central venous catheters: a prospective randomized trial. Arch Surg 1996 Sep; 131(9): 986–9PubMedCrossRef
236.
go back to reference George SJ, Vuddamalay P, Boscoe MJ. Antiseptic-impregnated central venous catheters reduce the incidence of bacterial colonization and associated infection in immunocompromised transplant patients. Eur J Anaesthesiol 1997 Jul; 14(4): 428–31PubMedCrossRef George SJ, Vuddamalay P, Boscoe MJ. Antiseptic-impregnated central venous catheters reduce the incidence of bacterial colonization and associated infection in immunocompromised transplant patients. Eur J Anaesthesiol 1997 Jul; 14(4): 428–31PubMedCrossRef
237.
go back to reference Logghe C, Van Ossel C, D’Hoore W, et al. Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. J Hosp Infect 1997 Oct; 37(2): 145–56PubMedCrossRef Logghe C, Van Ossel C, D’Hoore W, et al. Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. J Hosp Infect 1997 Oct; 37(2): 145–56PubMedCrossRef
238.
go back to reference Maki DG, Stolz SM, Wheeler S, et al. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial. Ann Intern Med 1997 Aug 15; 127(4): 257–66PubMed Maki DG, Stolz SM, Wheeler S, et al. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial. Ann Intern Med 1997 Aug 15; 127(4): 257–66PubMed
239.
go back to reference Tennenberg S, Lieser M, McCurdy B, et al. A prospective randomized trial of an antibiotic- and antiseptic-coated central venous catheter in the prevention of catheter-related infections. Arch Surg 1997 Dec; 132(12): 1348–51PubMedCrossRef Tennenberg S, Lieser M, McCurdy B, et al. A prospective randomized trial of an antibiotic- and antiseptic-coated central venous catheter in the prevention of catheter-related infections. Arch Surg 1997 Dec; 132(12): 1348–51PubMedCrossRef
240.
go back to reference Collin GR. Decreasing catheter colonization through the use of an antiseptic-impregnated catheter: a continuous quality improvement project. Chest 1999 Jun; 115(6): 1632–40PubMedCrossRef Collin GR. Decreasing catheter colonization through the use of an antiseptic-impregnated catheter: a continuous quality improvement project. Chest 1999 Jun; 115(6): 1632–40PubMedCrossRef
241.
go back to reference Sheng WH, Ko WJ, Wang JT, et al. Evaluation of antiseptic-impregnated central venous catheters for prevention of catheter-related infection in intensive care unit patients. Diagn Microbiol Infect Dis 2000 Sep; 38(1): 1–5PubMedCrossRef Sheng WH, Ko WJ, Wang JT, et al. Evaluation of antiseptic-impregnated central venous catheters for prevention of catheter-related infection in intensive care unit patients. Diagn Microbiol Infect Dis 2000 Sep; 38(1): 1–5PubMedCrossRef
242.
go back to reference Haxhe JJ, D’Hoore W. A meta-analysis dealing with the effectiveness of chlorhexidine and silver-sufhadiazine impregnated central venous catheters. J Hosp Infect 1998 Oct; 40(2): 166–8PubMedCrossRef Haxhe JJ, D’Hoore W. A meta-analysis dealing with the effectiveness of chlorhexidine and silver-sufhadiazine impregnated central venous catheters. J Hosp Infect 1998 Oct; 40(2): 166–8PubMedCrossRef
243.
go back to reference Veenstra DL, Saint S, Saha S, et al. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 1999 Jan 20; 281(3): 261–7PubMedCrossRef Veenstra DL, Saint S, Saha S, et al. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 1999 Jan 20; 281(3): 261–7PubMedCrossRef
244.
go back to reference Marin MG, Lee JC, Skurnick JH. Prevention of nosocomial bloodstream infections: effectiveness of antimicrobial-impregnated and heparin-bonded central venous catheters. Crit Care Med 2000 Sep; 28(9): 3332–8PubMedCrossRef Marin MG, Lee JC, Skurnick JH. Prevention of nosocomial bloodstream infections: effectiveness of antimicrobial-impregnated and heparin-bonded central venous catheters. Crit Care Med 2000 Sep; 28(9): 3332–8PubMedCrossRef
245.
go back to reference Pai MP, Pendland SL, Danziger LH. Antimicrobial-coated/ bonded and -impregnated intravascular catheters. Ann Pharmacother 2001 Oct; 35(10): 1255–63PubMedCrossRef Pai MP, Pendland SL, Danziger LH. Antimicrobial-coated/ bonded and -impregnated intravascular catheters. Ann Pharmacother 2001 Oct; 35(10): 1255–63PubMedCrossRef
246.
go back to reference McConnell SA, Gubbins PO, Anaissie EJ. Do antimicrobial-impregnated central venous catheters prevent catheter-related bloodstream infection? Clin Infect Dis 2003 Jul 1; 37(1): 65–72PubMedCrossRef McConnell SA, Gubbins PO, Anaissie EJ. Do antimicrobial-impregnated central venous catheters prevent catheter-related bloodstream infection? Clin Infect Dis 2003 Jul 1; 37(1): 65–72PubMedCrossRef
247.
go back to reference Brun-Buisson C, Doyon F, Sollet JP, et al. Prevention of intravascular catheter-related infection with newer chlorhexidine-silver-sulfadiazine-coated catheters. Intensive Care Med 2004; 30: 837–43PubMedCrossRef Brun-Buisson C, Doyon F, Sollet JP, et al. Prevention of intravascular catheter-related infection with newer chlorhexidine-silver-sulfadiazine-coated catheters. Intensive Care Med 2004; 30: 837–43PubMedCrossRef
248.
go back to reference Tattawasart U, Maillard JY, Furr JR, et al. Development of resistance to chlorhexidine diacetate and cetylpyridinium chloride in Pseudomonas stutzeri and changes in antibiotic susceptibility. J Hosp Infect 1999 Jul; 42(3): 219–29PubMedCrossRef Tattawasart U, Maillard JY, Furr JR, et al. Development of resistance to chlorhexidine diacetate and cetylpyridinium chloride in Pseudomonas stutzeri and changes in antibiotic susceptibility. J Hosp Infect 1999 Jul; 42(3): 219–29PubMedCrossRef
249.
go back to reference Oda T, Hamasaki J, Kanda N, et al. Anaphylactic shock induced by an antiseptic-coated central venous [correction of nervous] catheter [published erratum appears in Anesthesiology 1998 Feb; 88 (2): 560]. Anesthesiology 1997 Nov; 87(5): 1242–4PubMedCrossRef Oda T, Hamasaki J, Kanda N, et al. Anaphylactic shock induced by an antiseptic-coated central venous [correction of nervous] catheter [published erratum appears in Anesthesiology 1998 Feb; 88 (2): 560]. Anesthesiology 1997 Nov; 87(5): 1242–4PubMedCrossRef
250.
go back to reference Gosheger G, Hardes J, Ahrends H, et al. Silver-coated megaendoprostheses in a rabbit model: an analysis of the infection rate and toxicological side effects. Biomaterials 2004; 25(24): 5547–56PubMedCrossRef Gosheger G, Hardes J, Ahrends H, et al. Silver-coated megaendoprostheses in a rabbit model: an analysis of the infection rate and toxicological side effects. Biomaterials 2004; 25(24): 5547–56PubMedCrossRef
251.
go back to reference Sioshansi P. New processes for surface treatment of catheters. Artif Organs 1994 Apr; 18(4): 266–71PubMedCrossRef Sioshansi P. New processes for surface treatment of catheters. Artif Organs 1994 Apr; 18(4): 266–71PubMedCrossRef
252.
go back to reference McLean RJ, Hussain AA, Sayer M, et al. Antibacterial activity of multilayer silver-copper surface films on catheter material. Can J Microbiol 1993 Sep; 39(9): 895–9PubMedCrossRef McLean RJ, Hussain AA, Sayer M, et al. Antibacterial activity of multilayer silver-copper surface films on catheter material. Can J Microbiol 1993 Sep; 39(9): 895–9PubMedCrossRef
253.
go back to reference Davenas J, Thevenard P, Philippe F, et al. Surface implantation treatments to prevent infection complications in short term devices. Biomol Eng 2002 Aug; 19(2–6): 263–8PubMedCrossRef Davenas J, Thevenard P, Philippe F, et al. Surface implantation treatments to prevent infection complications in short term devices. Biomol Eng 2002 Aug; 19(2–6): 263–8PubMedCrossRef
254.
go back to reference Gatter N, Kohnen W, Jansen B. In vitro efficacy of a hydrophilic central venous catheter loaded with silver to prevent microbial colonization. Zentralbl Bakteriol 1998 Jan; 287(1–2): 157–69PubMedCrossRef Gatter N, Kohnen W, Jansen B. In vitro efficacy of a hydrophilic central venous catheter loaded with silver to prevent microbial colonization. Zentralbl Bakteriol 1998 Jan; 287(1–2): 157–69PubMedCrossRef
255.
go back to reference Jansen B, Rinck M, Wolbring P, et al. In vitro evaluation of the antimicrobial efficacy and biocompatibility of a silver-coated central venous catheter. J Biomater Appl 1994 Jul; 9(1): 55–70CrossRef Jansen B, Rinck M, Wolbring P, et al. In vitro evaluation of the antimicrobial efficacy and biocompatibility of a silver-coated central venous catheter. J Biomater Appl 1994 Jul; 9(1): 55–70CrossRef
256.
go back to reference Boswald M, Lugauer S, Regenfus A, et al. Reduced rates of catheter-associated infection by use of a new silver-impregnated central venous catheter. Infection 1999; 27 Suppl. 1: S56–60PubMedCrossRef Boswald M, Lugauer S, Regenfus A, et al. Reduced rates of catheter-associated infection by use of a new silver-impregnated central venous catheter. Infection 1999; 27 Suppl. 1: S56–60PubMedCrossRef
257.
go back to reference Ranucci M, Isgro G, Giomarelli PP, et al. Impact of oligon central venous catheters on catheter colonization and catheter-related bloodstream infection. Crit Care Med 2003 Jan; 31(1): 52–9PubMedCrossRef Ranucci M, Isgro G, Giomarelli PP, et al. Impact of oligon central venous catheters on catheter colonization and catheter-related bloodstream infection. Crit Care Med 2003 Jan; 31(1): 52–9PubMedCrossRef
258.
go back to reference Liu WK, Tebbs SE, Byrne PO, et al. The effects of electric current on bacteria colonising intravenous catheters. J Infect 1993 Nov; 27(3): 261–9PubMedCrossRef Liu WK, Tebbs SE, Byrne PO, et al. The effects of electric current on bacteria colonising intravenous catheters. J Infect 1993 Nov; 27(3): 261–9PubMedCrossRef
259.
go back to reference Raad I, Hachem R, Zermeno A, et al. In vitro antimicrobial efficacy of silver iontophoretic catheter. Biomaterials 1996 Jun; 17(11): 1055–9PubMedCrossRef Raad I, Hachem R, Zermeno A, et al. In vitro antimicrobial efficacy of silver iontophoretic catheter. Biomaterials 1996 Jun; 17(11): 1055–9PubMedCrossRef
260.
go back to reference Goldschmidt H, Hahn U, Salwender HJ, et al. Prevention of catheter-related infections by silver coated central venous catheters in oncological patients. Zentralbl Bakteriol 1995 Dec; 283(2): 215–23PubMedCrossRef Goldschmidt H, Hahn U, Salwender HJ, et al. Prevention of catheter-related infections by silver coated central venous catheters in oncological patients. Zentralbl Bakteriol 1995 Dec; 283(2): 215–23PubMedCrossRef
261.
go back to reference Carbon RT, Lugauer S, Geitner U, et al. Reducing catheter-associated infections with silver-impregnated catheters in long-term therapy of children. Infection 1999; 27 Suppl. 1: S69–73PubMedCrossRef Carbon RT, Lugauer S, Geitner U, et al. Reducing catheter-associated infections with silver-impregnated catheters in long-term therapy of children. Infection 1999; 27 Suppl. 1: S69–73PubMedCrossRef
262.
go back to reference Stoiser B, Kofler J, Staudinger T, et al. Contamination of central venous catheters in immunocompromised patients: a comparison between two different types of central venous catheters. J Hosp Infect 2002 Mar; 50(3): 202–6PubMedCrossRef Stoiser B, Kofler J, Staudinger T, et al. Contamination of central venous catheters in immunocompromised patients: a comparison between two different types of central venous catheters. J Hosp Infect 2002 Mar; 50(3): 202–6PubMedCrossRef
263.
go back to reference Bridgett MJ, Davies MC, Denyer SP, et al. In vitro assessment of bacterial adhesion to Hydromer-coated cerebrospinal fluid shunts. Biomaterials 1993 Feb; 14(3): 184–8PubMedCrossRef Bridgett MJ, Davies MC, Denyer SP, et al. In vitro assessment of bacterial adhesion to Hydromer-coated cerebrospinal fluid shunts. Biomaterials 1993 Feb; 14(3): 184–8PubMedCrossRef
264.
go back to reference Bayston R, Zdroyewski V, Barsham S. Use of an in vitro model for studying the eradication of catheter colonisation by Staphylococcus epidermidis. J Infect 1988 Mar; 16(2): 141–6PubMedCrossRef Bayston R, Zdroyewski V, Barsham S. Use of an in vitro model for studying the eradication of catheter colonisation by Staphylococcus epidermidis. J Infect 1988 Mar; 16(2): 141–6PubMedCrossRef
265.
go back to reference Bayston R, Barsham S. Catheter colonisation: a laboratory model suitable for aetiological, therapeutic and preventive studies. Med Lab Sci 1988 Jul; 45(3): 235–9PubMed Bayston R, Barsham S. Catheter colonisation: a laboratory model suitable for aetiological, therapeutic and preventive studies. Med Lab Sci 1988 Jul; 45(3): 235–9PubMed
266.
go back to reference Bayston R, Grove N, Siegel J, et al. Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnation with antimicrobials. J Neurol Neurosurg Psychiatry 1989 May; 52(5): 605–9PubMedCrossRef Bayston R, Grove N, Siegel J, et al. Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnation with antimicrobials. J Neurol Neurosurg Psychiatry 1989 May; 52(5): 605–9PubMedCrossRef
267.
go back to reference Bayston R, Milner RD. Antimicrobial activity of silicone rubber used in hydrocephalus shunts, after impregnation with antimicrobial substances. J Clin Pathol 1981 Sep; 34(9): 1057–62PubMedCrossRef Bayston R, Milner RD. Antimicrobial activity of silicone rubber used in hydrocephalus shunts, after impregnation with antimicrobial substances. J Clin Pathol 1981 Sep; 34(9): 1057–62PubMedCrossRef
268.
go back to reference Bayston R, Lambert E. Duration of protective activity of cerebrospinal fluid shunt catheters impregnated with antimicrobial agents to prevent bacterial catheter-related infection. J Neurosurg 1997 Aug; 87(2): 247–51PubMedCrossRef Bayston R, Lambert E. Duration of protective activity of cerebrospinal fluid shunt catheters impregnated with antimicrobial agents to prevent bacterial catheter-related infection. J Neurosurg 1997 Aug; 87(2): 247–51PubMedCrossRef
269.
go back to reference Bayston R, Ashraf W, Bhundia C. Mode of action of an antimicrobial biomaterial for use in hydrocephalus shunts. J Antimicrob Chemother 2004; 53: 778–82PubMedCrossRef Bayston R, Ashraf W, Bhundia C. Mode of action of an antimicrobial biomaterial for use in hydrocephalus shunts. J Antimicrob Chemother 2004; 53: 778–82PubMedCrossRef
270.
go back to reference Schierholz J, Jansen B, Jaenicke L, et al. In-vitro efficacy of an antibiotic releasing silicone ventricle catheter to prevent shunt infection. Biomaterials 1994 Oct; 15(12): 996–1000PubMedCrossRef Schierholz J, Jansen B, Jaenicke L, et al. In-vitro efficacy of an antibiotic releasing silicone ventricle catheter to prevent shunt infection. Biomaterials 1994 Oct; 15(12): 996–1000PubMedCrossRef
271.
go back to reference Hampl J, Schierholz J, Jansen B, et al. In vitro and in vivo efficacy of a rifampin-loaded silicone catheter for the prevention of CSF shunt infections. Acta Neurochir (Wien) 1995; 133(3–4): 147–52CrossRef Hampl J, Schierholz J, Jansen B, et al. In vitro and in vivo efficacy of a rifampin-loaded silicone catheter for the prevention of CSF shunt infections. Acta Neurochir (Wien) 1995; 133(3–4): 147–52CrossRef
272.
go back to reference Kohnen W, Schaper J, Klein O, et al. A silicone ventricular catheter coated with a combination of rifampin and trimethoprim for the prevention of catheter-related infections. Zentralbl Bakteriol 1998 Jan; 287(1–2): 147–56PubMedCrossRef Kohnen W, Schaper J, Klein O, et al. A silicone ventricular catheter coated with a combination of rifampin and trimethoprim for the prevention of catheter-related infections. Zentralbl Bakteriol 1998 Jan; 287(1–2): 147–56PubMedCrossRef
273.
go back to reference Hampl JA, Weitzel A, Bonk C, et al. Rifampin-impregnated silicone catheters: a potential tool for prevention and treatment of CSF shunt infections. Infection 2003 Mar; 31(2): 109–11PubMedCrossRef Hampl JA, Weitzel A, Bonk C, et al. Rifampin-impregnated silicone catheters: a potential tool for prevention and treatment of CSF shunt infections. Infection 2003 Mar; 31(2): 109–11PubMedCrossRef
274.
go back to reference Schierholz JM, Pulverer G. Investigation of a rifampin, fusidicacid and mupirocin releasing silicone catheter. Biomaterials 1998 Nov; 19(22): 2065–74PubMedCrossRef Schierholz JM, Pulverer G. Investigation of a rifampin, fusidicacid and mupirocin releasing silicone catheter. Biomaterials 1998 Nov; 19(22): 2065–74PubMedCrossRef
275.
go back to reference Zabramski JM, Whiting D, Darouiche RO, et al. Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J Neurosurg 2003 Apr; 98(4): 725–30PubMedCrossRef Zabramski JM, Whiting D, Darouiche RO, et al. Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J Neurosurg 2003 Apr; 98(4): 725–30PubMedCrossRef
276.
go back to reference von Eiff C, Overbeck J, Haupt G, et al. Bactericidal effect of extracorporeal shock waves on Staphylococcus aureus. J Med Microbiol 2000 Aug; 49(8): 709–12 von Eiff C, Overbeck J, Haupt G, et al. Bactericidal effect of extracorporeal shock waves on Staphylococcus aureus. J Med Microbiol 2000 Aug; 49(8): 709–12
277.
go back to reference Kohnen W, Bletz C, Hampl J, et al. Intelligent polymers for the prevention of device-related infection [poster no. S5]. 9th Annual Meeting of the Society of Healthcare Epidemiology of America; 1999 Apr 18–20; San Francisco Kohnen W, Bletz C, Hampl J, et al. Intelligent polymers for the prevention of device-related infection [poster no. S5]. 9th Annual Meeting of the Society of Healthcare Epidemiology of America; 1999 Apr 18–20; San Francisco
Metadata
Title
Infections Associated with Medical Devices
Pathogenesis, Management and Prophylaxis
Authors
Prof. Dr Christof von Eiff
Bernd Jansen
Wolfgang Kohnen
Karsten Becker
Publication date
01-02-2005
Publisher
Springer International Publishing
Published in
Drugs / Issue 2/2005
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI
https://doi.org/10.2165/00003495-200565020-00003

Other articles of this Issue 2/2005

Drugs 2/2005 Go to the issue

Adis Drug Profile

Cinacalcet Hydrochloride

Adis Drug Profile

Cinacalcet Hydrochloride

Adis Drug Evaluation

Abacavir plus Lamivudine